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Type 2 diabetes mellitus (T2D) is a metabolic disease characterized by
hyperglycemia, insulin resistance, dyslipidemia, and beta cell dysfunction. T2D
prevalence has been increasing with not all clear causes identified, while the use of
synthetic chemicals has risen. Because genetics can only explain a small percentage of
disease development, more attention is being given to associations of environmental
chemical exposure and disease. Epidemiological evidence suggests environmental
exposure to organochlorine compounds (OC) including dichlorodiphenyltrichloroethane
(DDT) and its bioaccumulative metabolite dichlorodiphenyldichloroethylene (DDE) is
associated with T2D prevalence and is hypothesized to play a role in contributing to T2D.
The purpose of this research was to perform an in vitro study of DDE exposure
and its effect on liver hepatocyte and pancreatic beta cell functions that regulate
biochemical markers implicated in T2D, and determine an association of DDE exposure
with T2D from a population exhibiting a high prevalence of T2D living in an area once
highly exposed to OC. Human blood samples from diabetics and non-diabetics were
analyzed for any significant association of DDE levels with biochemical markers of T2D

and T2D presence. The in vitro effect of DDE exposure on the regulation of hepatocyte
lipid metabolism and secretion with respect to triglyceride (TG), apolipoprotein B
(ApoB), sortilin-1 (Sort-1), and microsomal triglyceride transfer protein (MTP) levels
implicated in dyslipidemia was investigated. Finally, the in vitro effect of DDE exposure
on the regulation of beta cell insulin secretion with respect to insulin, oxidative stress
(ROS), prohormone convertase (PC), and pancreatic-duodenal homeobox-1(PDX-1)
levels implicated in beta cell dysfunction was investigated.
Based on our results, DDE levels were not associated with an increased risk of
T2D prevalence from this study population, although DDE levels were correlated with
some biochemical markers of T2D. ApoB secretion, Sort-1 and MTP levels were
increased after DDE exposure, while TG accumulation was decreased in hepatocytes.
Insulin secretion and PC levels were increased after DDE exposure, while ROS and
PDX-1 levels were increased but not significantly. Although no causative association of
DDE exposure with T2D prevalence was found, a potential mechanism of DDE’s effect
on regulating biochemical markers of T2D was identified.
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INTRODUCTION
Environmental Toxicology investigates the adverse effects of any biological,
chemical, and physical agents on living organisms and their environment. Thus, this field
of study explores how potentially toxic agents can directly or indirectly affect the
physiology of organisms and assess the risk associated with these substances that may be
hazardous to organisms and their environment. Indeed, the risks associated with these
toxic agents may outweigh the benefits of their usage. The overall significant impact of
this field of study is vital in increasing awareness for the better protection of human
health and the environment. Therefore, this project addresses these main ideas and
emphasizes the need for caution of future usage of potential environmental contaminants
by investigating the effects of known environmental contaminant exposure on public
health outcomes.
Historical Significance of DDE Exposure
Organochlorine compounds (OC) were synthetic chemicals used abundantly for
agricultural purposes throughout the world until banned for their adverse effects on
human health and the environment (Longnecker et al., 1997; EPA, 1999).
Dichlorodiphenyltrichloroethane (DDT) was developed as one of the first OC in the
1940s with worldwide potential for multiple uses as an insecticide (Morgan and Roan,
1971). DDT was cheaply manufactured and used in agriculture and industry for the
1

benefits of insect control in institutions, homes, and crops, and in pest control because of
its neurotoxic effects (CDC, 2012). DDT’s mechanism of action is to prevent closure of
the sodium channels in nerve cells causing them to fire rapidly producing hyperexcitability in an organism usually resulting in paralysis and death (Henderson and
Woolley, 1970; Davies et al., 2007). DDT was a very effective insecticide that was
administered for many years, until recognized for its adverse effects in the environment
(Sharpe and Irvine, 2004; Turusov et al., 2002). Although DDT was banned for use in
the United States by the 1970s, its bioaccumulative metabolite
dichlorodiphenyldichloroethylene (DDE) persists for years in the environment (EPA,
2011). A study on OC exposure in the general U.S. population revealed that serum DDT
levels were detected in the range of 2-58 ppb, while serum DDE levels were detected in
the range of 1-378 ppb (Murphy and Harvey, 1985). DDT accumulates in soil and is
slowly degraded by microorganisms over time to produce DDE (Fig. 1.). DDE, an
environmental contaminant, is highly lipophilic, slowly excreted from the body, and
levels in the body have the potential to increase throughout one’s lifetime based on its
biological half-life values (EPA, 1999). Exposure to residues of DDE is still possible and
can be detected in air, water, soil, and food samples (Fisher et al., 2003). In organisms
exposure to DDE residues has been detected in fat, urine, breast milk, and blood (EPA,
1999). Human exposure to DDE is mostly due to its existing presence in pre-exposure
high agriculture areas for past insecticide/pesticide use and from its biomagnification
throughout the food chain mainly from aquatic life and produce consumption (CDC,
2012). DDT’s half-life in soil is around 22 days to 15-30 years depending on conditions,
while DDT’s and DDE’s half-life is between 5-10 years in the body (ATSDR, 2002).
2

DDE exposure levels may represent a lifetime of exposure as individuals are potentially
exposed to DDE residues on multiple occasions. Exposure to these organic pollutants is
still possible and a worldwide threat due to their usage in underdeveloped countries
including Africa and India as insecticides for malaria control and on food products that
are imported to the United States (Fisher et al., 2003). Because genetics can only explain
a small percentage of disease development, more attention is being given to associations
of environmental chemical exposure and disease (Hunter, 2005). Data from the 19992002 National Health and Nutrition Examination Survey (NHANES) conducted by the
Centers for Disease Control and Prevention (CDC) identified an association of OC with
type 2 diabetes mellitus (T2D) (Lee et al., 2006; Lee et al., 2007). Based on data from
the CDC NHANES study, DDE was detected in 99.7% of human plasma samples, and
the highest concentration of DDE levels detected in human serum was around 16 µM
(which was similar to concentrations used in this study) after adjusting for adipose tissue
body burden of OC (CDC, 2012; Howell and Mangum, 2011). Research by others has
also shown that DDE exposure is associated with an increased risk for T2D prevalence
from a population once highly exposed to OC (Ukropec et al., 2010; Son et al., 2010). In
vivo animal studies by others has shown that DDT/DDE exposure as well as similar OC
are associated with an increased risk for obesity, insulin resistance, and other metabolic
disorders (La Merrill et al., 2014; Ruzzin et al., 2010). For example, in vivo OC exposure
has been implicated in altering liver function in mice such as affecting lipid metabolism
(Sato et al., 2008). Studies from Howell’s lab have shown that OC exposure affects
adipocyte function in vitro (Howell and Mangum, 2011). Research by others has shown
that OC exposure affects cell signaling mechanisms of liver cell function in vitro such as
3

regulating protein kinase C levels (Moser and Smart, 1989). Previous research has
shown an epidemiological association between individuals with or at risk for T2D and the
presence of higher levels of DDE in their blood (Lee et. al, 2006). Vietnam War
Veterans exhibiting exposure to the OC 2,3,7,8-tetrachlorodibenzodioxin (TCDD) have a
higher prevalence of insulin resistance and T2D (Kern et al., 2004). Research by others
has provided epidemiological evidence of an association between high exposure levels of
OC contaminants such as DDE, transnonachlor, and oxychlordane in plasma samples of
people with metabolic disorders and T2D (Lee at el., 2006). Furthermore, long-term
DDE exposure has been associated with an increased risk for biochemical markers of
dyslipidemia in diabetics and non-diabetics (Lee et. al, 2011). Long-term DDE exposure
has been implicated to predict abnormal lipid profiles in diabetics and non-diabetics over
time (Lee et. al, 2011). Long-term exposure to OC might affect how beta cells in the
pancreas synthesize and secrete insulin. Research by others has shown that rats exposed
to the OC endosulfan exhibited a dramatic increase in blood glucose levels compared to
non-exposed control groups (Kalender et al., 2004). Pancreatic beta cells of rats exposed
to endosulfan in vivo showed structural changes such as swelling of the mitochondria
implicating oxidative stress and mitochondrial dysfunction, possibly through the
induction of NADPH oxidase isoforms that regulate oxidative stress levels and by the
decreased production of adenosine triphosphate (ATP) in the mitochondria. Furthermore,
mice exposed to the OC TCDD exhibited reduced glucokinase gene expression and
glucose transporter transcript levels, causing a rise in blood glucose levels similar to that
of T2D (Sato et al., 2008), and impaired glucose-stimulated secretion of insulin in rat
treated islets (Novelli et al., 2005). TCDD is capable of decreasing glucose sensing by
4

the pancreas and impairs glucose stimulated insulin secretion (Hectors et al., 2011).
Although these results were observed from different OC, DDE exposure may exhibit
similar effects in vivo and in vitro. Scientific data suggest environmental exposure to
some of these OC is associated with T2D and may affect physiological functions in the
body that contribute to T2D (Lee et al., 2011; Lee et al., 2007). These epidemiological
and experimental data suggest a somewhat strong association between environmental
contaminant exposure and T2D, and implicate that there are more factors involved in the
development of T2D than over-nutrition and a lack of exercise, possibly environmental
factors (Lee et al., 2011). The epidemiological association of environmental contaminant
exposure with T2D remains inconclusive even though the rate of T2D has increased
(CDC, 2009).
Type 2 Diabetes Prevalence
T2D is a chronic metabolic disease characterized by hyperglycemia, insulin
resistance, dyslipidemia, and beta cell dysfunction (Keane et al., 2011). The major
complications that are associated with T2D are heart disease, stroke, obesity, high blood
pressure, blindness, kidney disease, neuropathy, amputation, and death (Amos et al.,
1997). T2D is the most common form of diabetes and affects between 90%-95% of the
millions of people living with all forms of diabetes in the United States (CDC, 2011).
The prevalence of T2D has increased dramatically over recent years with millions of
people being diagnosed in the United States each year (MSDH, 2012). Epidemiological
data indicates that 25.8 million children and adults in the United States, which accounts
for about 8.3% of the population, are living with T2D. Statistical analysis of this
population concludes that about 18.8 million people are diagnosed with diabetes, with 7
5

million people being undiagnosed (CDC, 2011). Unfortunately, 79 million people are
reported to be living with pre-diabetes, and new cases of T2D are being diagnosed in
people age 20 and older by the millions every year (Shaw et al., 2010). It is estimated
that the total cost of managing T2D reached 218 billion dollars in the United States in
2007 (CDC, 2011). Many factors are hypothesized as contributing to T2D (Kahn and
Flier, 2000). One factor such as exposure to common environmental contaminants could
play a role in the pathogenesis of T2D (Lee et al., 2006; Carpenter, 2008). Genetic
factors only account for about 15-25% of this prevalence, suggesting that other factors
including environmental factors may play a role in its pathogenesis (Hunter, 2005). The
prevalence of T2D has been increasing concurrent with the increasing use of synthetic
chemicals (Neel and Sargis, 2011).
The prevalence of T2D is higher in the southern region of the United States,
specifically the state of Mississippi (Fig. 2.). Mississippi’s Delta region has an extremely
high prevalence of T2D compared to the rest of the United States (CDC, 2008). The
Mississippi Delta region has higher exposure levels to OC compared to other regions of
Mississippi based on unpublished data from our lab investigating soil samples for OC
contamination throughout the entire state of Mississippi. The majority of residents in the
Delta region are African American, and African Americans have a greater risk of
developing T2D (CDC, 2011). These individuals are living in a region once highly
exposed to OC contaminants and exhibit high levels of biochemical markers associated
with T2D. Some of these biochemical markers include altered levels of insulin, free fatty
acids, very low density lipoproteins (VLDL), low density lipoproteins (LDL), high
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density lipoproteins (HDL), and changes in the levels of proteins associated with or that
regulate these biochemical markers.
The state of Mississippi is ranked in the top five of the unhealthiest states in the
United States. Mississippi is ranked second in the entire United States for overall
diabetes prevalence based on a 2010 study (MSDH, 2012). The Mississippi Delta region
has the highest prevalence of T2D in Mississippi (Mendy et al., 2015). Belzoni, MS is an
agricultural community that was once highly exposed to the synthetic chemical DDT.
DDT was declared illegal because of its hazardous effects to human health and the
environment and banned in 1972 for use in the United States (EPA, 2011). Although
many decades have passed since DDT was banned many countries still use DDT for the
benefit of agricultural and health reasons (Cohn et al., 2015). Because of this, high levels
of its metabolite, DDE, are still being identified in populations all over the world (Taylor
et al., 2013). This Mississippi Delta population is significant for the potential to exhibit
higher than normal levels of exposure to the OC DDE. Thus, individuals living in
Belzoni, MS may be a highly suitable population to investigate a potential association
between high exposure levels of DDE and T2D. This Delta population has never been
studied for the association of DDE exposure and T2D although the prevalence of T2D
has increased in this area.
Type 2 Diabetes and Liver Function
Individuals with T2D exhibit abnormal liver cell function. Insulin resistance
precedes T2D and occurs when cells in the body become insensitive to the action of
insulin (Martin et al., 1992). The liver is responsible for glucose production which is
regulated by insulin and glucagon levels. In the liver insulin regulates lipid and glucose
7

metabolism to maintain a healthy balance of lipid and glucose levels (Rader, 2007).
When the liver loses its ability to be regulated by insulin, lipid and glucose metabolism
are altered resulting in insulin resistance and hyperglycemia (DeFronzo and Ferrannini,
1991). During the progression of hyperglycemia cells in the body do not properly uptake
and utilize glucose for cellular functions such as for glucose storage, which eventually
results in excess glucose production by the liver and higher glucose levels in the blood.
Hyperglycemia further affects liver function such as contributing to dyslipidemia by
altering lipid metabolism (Michael et al., 2000). The effect of glucotoxicity in the liver
causes oxidative stress which alters cell signaling mechanisms that regulate lipid
metabolism and secretion such as fatty acid synthesis. Dyslipidemia, a state of altered
lipid levels, is characterized by an increased production of lipids including adipose
derived free fatty acids, lipid associated apolipoprotein B (ApoB), and triglycerides (TG)
into the circulatory system (Benoist and Grand-Perret, 1996).
Apolipoproteins are proteins that exist on the surface of lipoproteins, which are
composed internally of TG and cholesteryl esters. ApoB is a protein that binds to other
lipids to form lipoprotein molecules. Two forms of ApoB exist in the body and are
significantly associated with dyslipidemia and T2D (Ginsberg et al., 2005). ApoB-100 is
synthesized in the liver and is essential for the formation of VLDL. ApoB-48
synthesized primarily in the small intestine, is a truncated form of ApoB containing the
amino-terminal portion of ApoB-100, and is essential for the formation of chylomicrons
(Veniant et al., 1998). ApoB-48 is synthesized as a result of ApoB mRNA splicing (Liu
et al., 2010). ApoB-100 is the main protein component of lipoproteins including VLDL.
One VLDL particle consists of one ApoB molecule and numerous attached TG and
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cholesterol molecules. ApoB is an atherogenic related protein whose levels are increased
by the presence of free fatty acids and decreased by the action of insulin (Jin et al., 2008).
Free fatty acids stimulate ApoB secretion by providing an abundance of TG to nascent
ApoB molecules therefore increasing ApoB translocation across the ER membrane
(Macri and Adeli, 1997). ApoB plays an important role in lipid transport and clearance
in the body. For example, ApoB is important in transporting lipids such as TG to other
tissues in the body to be used for energy by facilitating the binding of lipoprotein
molecules to their cell receptors (Fisher and Ginsberg, 2002). It is necessary for the
synthesis and secretion of TG containing lipoproteins such as VLDL (Boren et al., 1994).
The increased secretion of ApoB associated lipids thus increases circulatory levels of TG,
cholesterol, and VLDL particles thereby promoting dyslipidemia (Julius, 2003). ApoB
levels are significantly higher in individuals exhibiting dyslipidemia and T2D (Qiu et. al,
2006).
TG are synthesized as a product of free fatty acid hydrolysis by liver enzymes
including triacylglycerol hydrolases/carboxylesterases (TGH) (Lehner and Verger, 1997)
and serve as secondary energy source after carbohydrates for cellular functions (Howard,
1987). TG are a biochemical marker implicated in T2D and levels are usually higher in
individuals with diabetes compared to non-diabetics (Albrink and Man, 1958). The
increased levels of TG in the liver are a result of free fatty acid efflux from lipolysis,
uptake of VLDL and chylomicron remnants, re-esterification by TGH, and hepatic
lipogenesis during insulin resistance (Ginsberg et al., 2005). TG are a companion
biochemical marker for ApoB molecules. TG are composed of a glycerol molecule
attached to three fatty acids. Sufficient triglyceride levels are important in the formation
9

of nascent ApoB to form a completed ApoB molecule, which is secreted by the liver or
small intestine into the bloodstream attached to other lipids (Sparks et al., 2012).
Otherwise, in the absence of sufficient TG levels, ApoB remains in its nascent form and
is degraded by intracellular proteasomes resulting in a decrease of ApoB secretion.
Excess TG levels or hypertriglyceridemia is associated with T2D (Julius, 2003).
The ability of TG molecules to attach to nascent ApoB molecules is regulated by
microsomal triglyceride transfer protein (MTP) and the enzyme TGH (Manchekar et al.,
2004). The rate-limiting step for ApoB synthesis, assembly, and secretion involves the
joint action of MTP and TGH (Lehner and Verger, 1997). MTP is an endoplasmic
reticulum related protein that is important in the transfer of lipids between vesicles
(Hussain et al., 2003). MTP is a lipid transporter protein that regulates lipidation of
lipoprotein molecules for secretion. MTP is important in the transport of neutral lipids
including cholesterol and TG to nascent ApoB in order to form complete ApoB
lipoproteins (Taghibiglou et. al, 2000). Research by others has shown that MTP levels
are associated with T2D in vivo. Increased MTP levels will result in the increased
synthesis and secretion of TG containing ApoB lipids that contribute to T2D
development (Bartels et al., 2002). The interaction of MTP with ApoB preserves ApoB
from intracellular degradation and promotes lipidation (lipid assembly) and lipid
secretion (Higuchi et al., 2011).
In the absence of increased MTP levels, ApoB is degraded by intracellular
proteasomes and secretion is decreased due to the increased protein levels of sortilin-1
(Sort-1) (Cardozo et al., 2002). Sort-1 is an intracellular protein that regulates ApoB
degradation (Strong and Rader, 2012). During normal liver cell function, Sort-1 binds to
10

ApoB and transports it to the proteasome for degradation to maintain a homeostasis of
lipid secretion. Although ApoB is degraded, basal levels of ApoB are still secreted from
the liver and small intestine at a homeostatic rate (Chamberlain et al., 2013). A
disruption of this homeostatic rate regulated by Sort-1 could affect how lipids are
secreted from the liver thereby contributing to complications associated with
dyslipidemia and T2D. Insulin levels positively regulate Sort-1 protein levels. For
example, Sort-1 levels were found to be decreased in in vivo and in vitro models of
insulin resistance and diabetes along with an increase in ApoB and MTP levels from the
liver (Ai et al., 2012). Therefore, Sort-1 plays a very important role in regulating ApoB
levels in the body.
T2D can result in altered lipid levels as well as the altered levels of proteins
attached to these lipids. Paraoxonase-1 (PON) is an endogenous serum esterase attached
to HDL molecules found in the blood (Aviram et al., 1999). PON is synthesized and
secreted by the liver in high amounts and lower amounts in other tissues (Abbott et al.,
1995). The main functions of PON are protection against oxidative stress by preventing
lipid oxidation, hydrolysis of esters, and increasing antioxidant levels (Costa et al., 2005).
PON protects LDL from forming oxidized lipid products induced by oxidative stress
(Furlong et al., 2010). PON is non-specific and has the ability to hydrolyze
organophosphate compounds such as paraoxon, the metabolite of parathion, therefore
making it protective against organophosphate pesticide poisoning (Boesch-Saadatmandi
et al., 2010). Previous data concluded that PON levels are decreased in cases of T2D
(Manning et al., 2012). It is well established that African Americans are at a greater risk
for metabolic diseases and exhibit differences in PON activity compared to Caucasians
11

(Davis et al., 2009). Furthermore, exposure to OC is associated with changes in lipid
profiles in vivo (Shamir et al., 2005). OC exposure may play a role in the alteration of
PON levels identified in individuals with altered lipid profiles exhibiting T2D (Saha et
al., 1991). For example research from our laboratories show that the OC dieldrin affects
PON levels in vitro by the induction of nuclear receptors that regulate PON synthesis
(Dail et al., 2014). The potential association of OC exposure with PON levels may
complement the association of OC exposure with abnormal lipid profiles and T2D.
Type 2 Diabetes and Pancreatic Function
The function of the pancreas to regulate insulin is impaired in T2D (Lim et al.,
2011). Insulin is produced by the beta cells of the pancreas in response to elevated
extracellular glucose concentrations in the body. This extracellular glucose enters
pancreatic beta cells through glucose transporters (GLUT2) by facilitated diffusion across
the cell membrane (Skelin et al., 2010). Once inside the cell, glucose is metabolized by
the enzyme glucokinase to glucose-6-phosphate and then to pyruvate which enters the
tricarboxylic acid cycle in the mitochondria to increase the production of adenosine
triphosphate (ATP). ATP binds to and closes the ATP-dependent-potassium channel in
the plasma membrane resulting in depolarization of the plasma membrane. This
membrane depolarization results in the opening of the voltage-gated calcium channels
and an increase in influx of extracellular calcium. High levels of calcium influx raises
the cell’s electrical activity and cause insulin secretory granules to travel to the plasma
membrane to eventually release insulin from beta cells (Ashcroft and Rorsman, 1989).
The pancreas is responsible for insulin production which is regulated by glucose levels.
In the pancreas beta cells uptake excess glucose from the blood and secrete insulin to
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further regulate glucose levels in other cells of the body (Schuit et al., 2001).
Hyperglycemia is detrimental to pancreatic beta cell function. Excess glucose levels or
glucotoxicity alter the function of beta cells to synthesize and secrete insulin.
Glucotoxicity causes oxidative stress in beta cells which blunt cell signaling mechanisms
responsible for insulin regulation such as the production of sufficient ATP levels. Longterm hyperglycemia causes beta cells to secrete high amounts of insulin in a short amount
of time (Leahy et al., 1992). Beta cells continue to secrete high amounts of insulin
resulting in hyperinsulinemia until these cells lose their ability to secrete sufficient levels
of insulin over time resulting in beta cell burnout and beta cell dysfunction (Porte and
Kahn, 2001).
Beta cell dysfunction is a state of altered cellular function in pancreatic beta cells
including changes in intracellular oxidative stress levels, insulin synthesis, and insulin
secretion (Makaji et al., 2011). During beta cell dysfunction the regulation of insulin
synthesis is disrupted at the site of transcription, post-translational modification, and
secretion in beta cells. Individuals with T2D exhibit a decline in the ability of their
pancreatic beta cells to properly regulate or produce sufficient amounts of insulin as
result of insulin resistance, which leads to beta cell dysfunction and depletion of beta cell
mass (Dixon et al., 2004). Hyperglycemia in T2D results from defective insulin secretion
and impaired insulin action on target tissues or insulin resistance, which produces a rise
in circulating blood glucose levels with T2D progression (McClenaghan, 2007). The
decline in pancreatic beta cell function in T2D has been linked to glucose toxicity.
Hyperglycemia adversely affects beta cells by causing defective insulin secretion
(Robertson et al., 2003). Individuals that exhibit less beta cell mass or less effective beta
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cell function are at a higher risk for developing T2D (Tushuizen et al., 2007). Insulin
resistance that is accompanied by the dysfunction of pancreatic islet beta cells results in
failure to control blood glucose levels (Kahn, 2003). Abnormalities in beta cell function
are critical in defining the risk and development of T2D (Kahn et al., 2006). Therefore,
biochemical markers of beta cell dysfunction ranging from insulin synthesis, secretion,
and insulin regulatory proteins are potential contributors to the development of T2D
(Weir, 2004).
The main function of insulin is to increase cell permeability to monosaccharides,
amino acids, and fatty acids (Itoh et al., 2003). Insulin blunts the use of fat as an energy
source by inhibiting the release of glucagon. Insulin is provided within the body in a
constant proportion to remove excess glucose from the blood (Duckworth et al., 1998).
Insulin can be regulated by endogenous lipids and proteins, but glucose is the primary
regulator of insulin. Insulin is secreted at basal levels from beta cells in the absence of
glucose and secretion is increased in response to stimulatory glucose levels (Schuit et al.,
1988). The body utilizes insulin to decrease circulatory blood glucose levels by inducing
the liver to decrease glucose production and the adipose and muscle tissue to uptake and
metabolize glucose for energy use or storage in order to maintain normal blood glucose
homeostasis (Abel et al., 2001).
The insulin molecule is regulated enzymatically in phases during synthesis.
Insulin is the metabolite of preproinsulin, which is a precursor molecule formed from
insulin gene transcription (Bollheimer et al., 1998). During post-translational
modification, preproinsulin is cleaved by the serine protease, prohormone convertase
(PC), to proinsulin. PC is an enzyme whose main function is to regulate the proteolytic
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cleavage of incomplete peptides to their complete forms. The proinsulin molecule is
further cleaved by PC to yield two products: mature insulin and connecting (C)-peptide
(Fu et al., 2013). PC levels are important in the diagnosis of T2D as changes in these
levels have been associated with biochemical markers of the metabolic syndrome. PC
regulates the synthesis of insulin by multiple steps: transcription from the insulin gene,
protein translation, and post-translational modification of protein conformation (Weiss,
2009). Disruption of this enzymatic pathway contributes to altered insulin homeostasis
and beta cell dysfunction (Rhodes and Alarcon, 1994).
Pancreatic-Duodenal Homeobox 1 (PDX-1) is a transcription factor present in
beta cells. It plays a vital role in regulating insulin gene transcription. The function of
PDX-1 depends on the cellular metabolism of glucose and the production of oxidative
stress. PDX-1 exists as an inactive protein in the cytoplasm of beta cells and translocates
to the nucleus of beta cells as an active protein via glucose induced phosphorylation
(Macfarlane et al., 1999). PDX-1 has been shown to regulate the expression of a number
of proteins involved in glucose sensing, insulin secretion, and genes involved in
pancreatic islet growth and development including insulin, glucokinase, and islet amyloid
polypeptide (McKinnon and Docherty, 2001). PDX-1 has been shown to induce insulin
and glucokinase gene expression (Watada et al., 1996). Research by others has shown
that the reduced expression of PDX-1 is associated with beta cell dysfunction and
hyperglycemia. For example, research by others has shown that mutations in the PDX-1
gene could lead to abnormalities in islet function that has the potential to result in T2D in
humans and mice (Brissova et al., 2005).
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Increased oxidative stress has been associated with cases of T2D (Kahn, 2003).
Oxidative stress occurs when the levels of reactive oxygen species (ROS) are higher than
the levels of antioxidant molecules in a cell. Oxidative stress occurs naturally in cells
through normal cell function and metabolism. Oxidative stress has a major influence on
beta cell function and is a product of glucose induced insulin secretion (Evans et al.,
2003). Pancreatic beta cells express lower levels of antioxidant enzymes and are highly
vulnerable to damage by oxidative stress markers induced by endogenous factors such as
excess glucose or lipids including free fatty acids. Oxidative stress can result in damage
to DNA, lipids, and proteins in cells (Klaunig et al., 1998). ROS are biochemical
markers of oxidative stress. Common ROS include superoxide (O2-), hydroxyl radical
(OH·), and hydrogen peroxide (H2O2). DDE exposure has been known to play a role in
the induction of these oxidants in vitro. ROS generation is dependent upon the activity of
membrane bound NADPH oxidase and its isoforms. DDE exposure has been shown to
increase the levels of some of these NADPH oxidase isoforms in vitro (Song et al., 2014).
ROS target many signal transduction molecules in pancreatic beta cells that regulate
insulin secretion and beta cell function. DDE exposure results in an elevation of ROS
levels in vitro, and an association between increased ROS levels and alterations in the
insulin signaling pathway has been demonstrated (Pi et al., 2007).
Scientific Rationale and Study Approach
Environmental exposure to OC is associated with T2D and may be a potential risk
factor that contributes to T2D prevalence by its hypothesized effects on regulating
biochemical markers of T2D in vitro. The epidemiological association of T2D with OC
exposure has yet to be solved. The purpose of this study was to investigate an association
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of DDE exposure with biochemical markers of T2D or with T2D presence from an at-risk
population for metabolic diseases as well as investigate an association of DDE exposure
with biochemical markers of T2D in vitro to investigate DDE exposure as a risk factor
for T2D. The overall hypothesis of this study is that potentially exhibiting high DDE
levels is a risk factor associated with biochemical markers of T2D and the increased
prevalence of T2D. Following thorough investigation, this study will answer whether
DDE exposure plays a role in T2D prevalence reported by others by observing DDE’s
epidemiological association with biochemical markers of T2D and by investigating
DDE’s in vitro effect on mechanisms of liver hepatocytes and pancreatic beta cells that
regulate these biochemical markers of T2D. Therefore, this study demonstrated the need
for an in vitro scientific investigation into the means behind this association. Liver cell
hepatocyte function was studied for the effects of DDE that could lead to changes in
biochemistry that are reflective of T2D. Pancreatic beta cell function was studied for the
effects of DDE that could lead to changes in biochemistry that are reflective of T2D.
Finally, the significance of OC exposure with T2D was investigated through an
epidemiological study that identified biochemical markers of metabolic disease between
diabetic and non-diabetic individuals exhibiting high DDE exposure. These findings
could contribute to the overall understanding of environmental exposure and metabolic
disease development.
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Figure 1

Organochlorine compound structure of dichlorodiphenyltrichloroethane
(DDT) and its metabolite dichlorodiphenyldichloroethylene (DDE).

Figure 2

Map of the Mississippi Delta region.
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IN VITRO EFFECT OF DDE EXPOSURE ON THE REGULATION OF LIPID
METABOLISM AND SECRETION IN MCA-RH7777 HEPATOCYTES: A
POTENTIAL ROLE IN DYSLIPIDEMIA ASSOCIATED
WITH TYPE 2 DIABETES MELLITUS
Introduction
Environmental exposure to the organochlorine compound (OC) contaminant
dichlorodiphenyldichloroethylene (DDE) is associated with type 2 diabetes mellitus
(T2D) according to epidemiological studies and may play a role in risk factors that
contribute to T2D such as dyslipidemia (Lee et al, 2011). Dyslipidemia, a state of altered
lipid levels, plays a role in the progression of insulin resistance and T2D (Rader, 2007).
Exposure to environmental contaminants is a possible factor that could play a role in the
pathogenesis of T2D (Lee et al., 2006; Carpenter, 2008). DDE exposure has been
associated with biochemical markers of dyslipidemia (Lee et al., 2011). The liver is a
potential target for DDE exposure since it plays a role in regulating lipid metabolism and
secretion (Fig. 3.) and a disruption of this process by DDE exposure may cause
dyslipidemia to occur (Mulvihill et al., 2009).
The purpose of this study was to investigate any changes that may occur in free
fatty acid induced lipid metabolism and secretion of McArdle-RH7777 (McA)
hepatocytes exposed to DDE in vitro with respect to biochemical markers identified in
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dyslipidemia including apolipoprotein B (ApoB), microsomal triglyceride transfer protein
(MTP), sortilin-1 (Sort-1), and triglycerides (TG). ApoB is a lipoprotein molecule
synthesized in the liver, important in lipid transport and clearance, and is needed for the
synthesis and secretion of TG containing lipids such as very low-density lipoproteins
(VLDL) from the liver (Boren et al., 1994). ApoB levels are significantly higher in
individuals exhibiting dyslipidemia and T2D (Qiu et. al, 2006). The increased secretion
of ApoB molecules thus increases circulatory levels of TG, cholesterol, and VLDL
particles thereby promoting dyslipidemia (Julius, 2003). TG are synthesized from free
fatty acids that are metabolized in the liver and serve as a secondary energy source after
carbohydrates for cellular functions (Howard, 1987). TG are important in the formation
of nascent ApoB to form a completed ApoB molecule, which is then secreted by the liver
or small intestine into the bloodstream (Sparks et al., 2012). TG are a biochemical
marker implicated in T2D and levels are usually higher in individuals with diabetes
compared to non-diabetics (Albrink and Man, 1958). The rate-limiting step for ApoB
synthesis, assembly, and secretion involves the action of MTP and TGH (Hussain et al.,
2003; Lehner and Verger, 1997). MTP is important in the transport of neutral lipids
including cholesterol and TG to nascent ApoB in order to form complete ApoB
lipoproteins (Taghibiglou et. al, 2000). The interaction of MTP with ApoB preserves
ApoB from intracellular degradation and promotes lipidation (lipid assembly) and lipid
secretion (Cardozo et al., 2002). Sort-1 is an intracellular protein that regulates ApoB
degradation (Strong and Rader, 2012). Sort-1 binds to ApoB in the liver and transports it
to the proteasome for degradation to maintain a homeostatic level of lipid secretion

30

(Chamberlain et al., 2013). Sort-1 protein levels were found to be decreased in in vivo/in
vitro models of insulin resistance and T2D (Ai et al., 2012).
The hypothesis of this study is that exposure to DDE will alter lipid synthesis,
accumulation, transport, degradation, and/or secretion in McA cells. The goal was to
identify in vitro effects of DDE on McA cell mechanisms involved in lipid metabolism
and secretion. The rodent hepatoma McA cell line was used as a mechanistic model for
liver cell function. McA cells secrete lipids in response to fatty acids and are a reliable
cell line for studying lipid metabolism and secretion (Boren et al., 1994). McA liver cells
are significant because they secrete both ApoB-100 and its truncated form, ApoB-48, and
in vivo studies by others using rodent models indicate that both forms of ApoB are
secreted from the liver (Veniant et al., 1998). McA cells are beneficial for studying lipid
metabolism and secretion as they express biochemical pathways similar to lipid signaling
pathways identified in primary hepatocytes. McA cells express the transcription factor
Srebp-1c needed for lipid synthesis, but lack expression of the TGH needed for lipid
assembly while relying on only MTP expression for lipid assembly. However, McA cells
express both forms of ApoB while human primary hepatocytes do not, therefore limiting
this cell line as the best model for studying lipid metabolism and secretion. McA cells
also show differences in glucose and fatty acid uptake when compared to primary
hepatocytes (Hansson et al., 2004). McA cells are derived from a cancerous cell line (rat
hepatomas) and do not completely represent normal hepatocyte function as compared to
using primary cells of human origin.
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Materials and Methods
The McArdle-RH7777 (McA) rodent cell line was purchased from American
Tissue Culture Collection (Manassas, VA). 10% Neutral Buffered Formalin, Super
Signal West Pico Chemiluminescence kit, 0.05% trypsin in 0.53mM
ethylenediaminetetraacetic acid (EDTA) solution, and Sort-1 antibody were purchased
from Thermo Fisher Scientific (Pittsburgh, PA). Certified fetal bovine serum (FBS),
Dulbecco’s Modified Eagles Medium (DMEM) complete growth medium, and penicillinstreptomycin were purchased from Invitrogen (Grand Island, NY). p,p’-DDE was
purchased from Chem Service (West Chester, PA). Phosphate buffered saline (PBS) was
purchased from Mediatech Inc. (Manassas, VA). Non-fat dry milk and Bradford protein
assay kit were purchased from Bio-Rad (Hercules, CA). ApoB antibody, goat anti-rabbit
IgG-HRP, donkey anti-goat IgG-HRP, beta-actin antibody, radio-immunoprecipitation
assay (RIPA) lysis buffer system, and Western Blotting Luminol Reagent were purchased
from Santa Cruz (Dallas, TX). MTP antibody was purchased from Aviva Systems
Biology (San Diego, CA) and Santa Cruz (Dallas, TX). Bovine serum albumin-fatty acid
free (BSA), oleic acid (OA) conjugated to BSA, Oil-red-O dye, 2X-sodium dodecyl
sulfate (SDS) sample loading buffer, and dimethyl sulfoxide (DMSO) were purchased
from Sigma Aldrich (St. Louis, MO). Triglyceride (TG) assay kit was purchased from
Cayman Chemicals (Ann Arbor, MI). Crystal violet dye solution was purchased from
Active Motif (Carlsbad, CA).
McA cells were grown in supplemented DMEM containing 20% FBS and a 1%
solution of 100 IU/ml penicillin with 0.1 mg/ml streptomycin in a humidified atmosphere
of 5% carbon dioxide and 95% air at 37°C in a T-75 cell culture flask until 70%-90%
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confluent. Confluent cells were washed with PBS and detached from the culture flask
with a solution of 0.05% trypsin in 0.53mM EDTA. Cells were pelleted by
centrifugation and re-suspended in supplemented DMEM to be seeded overnight in a 12well cell culture plate to adhere. The next day supplemented DMEM was removed and
adherent cells were washed with PBS and treated with serum-free DMEM to starve cells
of serum during an overnight incubation. Following overnight incubation, serum-free
DMEM was removed and cells were washed with PBS and subjected to the following
experimental protocols.
Experimental Design
Experiment 1. The effect of free fatty acid exposure on McA liver cell lipid
secretion was investigated with respect to ApoB protein levels. OA, a free fatty acid, was
used to induce lipid metabolism and secretion in McA liver cells based on studies by
others. Following standard cell culture protocols, serum starved cells were treated with
either a final concentration of 400 µM OA conjugated to 1.2% BSA, 100 µM OA
conjugated to 0.3% BSA, or 1.2 % BSA only in DMEM (OA is conjugated to BSA and
the concentration of BSA varies based on the concentration of OA) for 24 hours for a
total of 3 treatment groups repeated in triplicate in each of 3 individual experimental
trials. Cell media was assayed for the detection of secreted ApoB protein levels using
SDS-PAGE with Western Blot Analysis.
Experiment 2. The concentration-response effect of DDE exposure on free fatty
acid induced lipid secretion of ApoB was investigated. Serum starved cells were exposed
to final concentrations of 1, 10, or 100 µM DDE dissolved in 0.1% DMSO
simultaneously with 400 µM OA conjugated to 1.2% BSA or 400 µM OA conjugated to
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1.2% BSA only in DMEM for 24 hours for a total of 4 treatment groups repeated in
triplicate in each of 3 individual experimental trials. Cell media was assayed for the
detection of secreted ApoB protein levels using SDS-PAGE with Western Blot Analysis.
Cell lysates were assayed for intracellular ApoB, MTP, and Sort-1 protein levels using
SDS-PAGE with Western Blot Analysis.
Experiment 3. Following the concentration-response analysis, the effect of DDE
exposure on free fatty acid induced lipid secretion was investigated using a single
concentration (10 µM) DDE. To investigate the effect of DDE exposure on free fatty
acid induced lipid secretion, serum starved cells were exposed to 10 µM DDE
simultaneously with 100 or 400 µM OA conjugated to 0.3 or 1.2% BSA, 100 or 400 µM
OA conjugated to 0.3 or 1.2% BSA, 10 µM DDE, or 0.3 or 1.2% BSA only in DMEM
for 24 hours for a total of 4 treatment groups repeated in triplicate in each of 3 individual
experimental trials. Cell media was assayed for the detection of secreted ApoB protein
levels using SDS-PAGE with Western Blot Analysis. Cell lysates were assayed for
intracellular ApoB, MTP, and Sort-1 protein levels using SDS-PAGE with Western Blot
Analysis.
Experiment 4. The effect of DDE exposure on free fatty acid induced TG
accumulation in McA cells was investigated. Serum starved cells were exposed to 10 µM
DDE simultaneously with 100 µM OA conjugated to 0.3% BSA, 100 µM OA conjugated
to 0.3% BSA, 10 µM DDE, or 0.3% BSA only in DMEM for 24 hours for a total of 4
treatment groups repeated in triplicate in each of 3 individual experimental trials. Cell
lysates were subjected to a colorimetric assay for the detection of TG accumulation in
liver cells (Cayman Chemicals).
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Experiment 5. The effect of DDE exposure on free fatty acid induced TG
secretion was investigated. Serum starved cells were exposed to 10 µM DDE
simultaneously with 100 µM OA conjugated to 0.3% BSA, 100 µM OA conjugated to
0.3% BSA, 10 µM DDE, or 0.3% BSA only in DMEM for 24 hours for a total of 4
treatment groups repeated in triplicate in each of 3 individual experimental trials. Cell
media was subjected to lipid extraction techniques (Folch et al., 1957) for the detection of
secreted lipid molecules and then analyzed using a colorimetric assay for the detection of
secreted TG molecules from liver cells (Cayman Chemicals).
Experiment 6. The effect of DDE exposure on free fatty acid induced neutral
lipid accumulation (triglycerides and cholesteryl esters) in McA liver cells was
investigated. Serum starved cells were exposed to 10 µM DDE or simultaneously with
100 µM OA conjugated to 0.3% BSA, 100 µM OA conjugated to 0.3% BSA, or 0.3%
BSA only in DMEM for 24 hours for a total of 4 treatment groups repeated in triplicate in
each of 3 individual experimental trials. Following experimentation, adherent cells were
analyzed for the detection of lipid accumulation using lipid staining techniques.
Assay Development
Assay 1. Bradford Protein Analysis. Following all experimental protocols, the
cell media was collected and stored at -80°C and cells were washed with PBS and lysed
in RIPA buffer with or without protease and phosphatase inhibitors and stored at -80°C
for future analysis. The protein concentrations of whole cell lysates were separated from
cell debris after centrifugation at 16.1 relative centrifugal force for 4°C using an Allegra
X-14R Centrifuge (Beckman Coulter). The diluted protein concentrations of cell media
and lysates from each treatment group were quantified by the Bradford protein assay. All
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treatment groups were normalized to the protein concentrations of their respective cell
lysates for Western Blot Analysis.
Assay 2. SDS-PAGE with Western Blot Analysis. Protein concentrations were
normalized for all treatment samples using 50 mM Tris-hydrochloride buffer (pH 7.4 at
4°C). Equal amounts of 2X-SDS sample loading buffer were added to each treatment
sample at a 1:1 dilution. Diluted protein samples (25 µg) were heated at 95°C and
allowed to cool. After cooling, samples were pipetted at equal volumes per well on a
10% polyacrylamide gel and subjected to electrophoresis for the separation of protein
bands by molecular weight at 100 volts for 15 minutes and 120 volts for 1 hour using a
Mini-PROTEAN 3 system. Following electrophoresis, the gel containing the protein
bands was transferred to a 0.45 μm polyvinylidene fluoride (PVDF) membrane with
electrophoresis at 20 volts for 30 minutes using a Trans-Blot SD semi-dry electrophoretic
transfer cell system (Bio-Rad). After a successful transfer, ApoB, MTP, or Sort-1 protein
levels were detected on a 0.45 μm PVDF membrane using the following antibodies:
ApoB-primary antibody, MTP-primary antibody, Sortilin-1-primary antibody, beta-actinprimary antibody, goat anti-rabbit IgG-HRP-secondary antibody, and donkey anti-goat
IgG-HRP-secondary antibody. Membranes were incubated with a blocking solution (5%
milk) to prevent non-specific binding of antibodies. Following successful blocking,
membranes were incubated with primary antibodies diluted 1:500 at 4°C overnight.
After overnight incubation, membranes were washed with a solution of Tris-buffered
saline containing 0.05% Tween-20 for 15 minutes. After washing, membranes were
incubated with secondary antibodies diluted 1:2000 for 1 hour at room temperature to
detect protein bands. After washing again for 15 minutes, membranes containing the
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appropriate antibody conjugated proteins were subjected to a chemical reaction of a 1:1
combination of super signal peroxide and luminol enhancer solution for 1 minute. The
horseradish peroxidase conjugated to the secondary antibody mediated the oxidation of
luminol in the presence of hydrogen peroxide resulting in light emission or
chemiluminescence. Following this reaction, protein bands were visualized using the
Chemi-Doc XRS System with Image Lab Software (Bio-Rad). Protein band density was
interpreted using ImageJ Software supplied by the National Institutes of Health (NIH).
Assay 3. Lipid Extraction Analysis. One milliliter of a chloroform:methanol
(2:1) solution was added to the cell media of each sample. Samples were vortexed and
incubated for 1 hour on ice. Following incubation, 200 µl of water was added to each
sample and samples were vortexed and centrifuged at 3,000 x g for 5 minutes. After
centrifugation, the supernatant was discarded and the lower lipid phase of each solution
was collected and allowed to dry at room temperature under nitrogen gas. The remaining
pellet of each sample was redissolved in a solution of 60 µl tert-butanol combined with a
40 µl solution of Triton-X-100:methanol (2:1) and vortexed. Redissolved lipid molecules
were collected and subjected to a colorimetric assay for the detection of TG efflux from
liver cells (Cayman Chemicals).
Assay 4. TG Analysis. Ten µl of lipid extracted cell media or cell lysate samples
per treatment were pipetted into a 96-well microplate. One hundred fifty µl of a diluted
enzyme mixture was added to each sample well to initiate the hydrolysis of TG to free
fatty acid and glycerol. Glycerol is further metabolized by the enzyme mixture to
hydrogen peroxide. Hydrogen peroxide then reacts with the enzyme mixture to produce a
purple colored product. Samples were incubated at room temperature for 15 minutes to
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allow the enzymatic reaction to take place. Following incubation, TG levels were
detected by measuring the absorbance of this purple product from each sample well at
540 nm using a SpectraMax M5 spectrophotometer (Molecular Devices). TG levels were
quantified using a TG standard curve from a dilution of purified TG standard.
Assay 5. Oil-red-O Lipid Analysis. McA cells were washed in PBS and fixed to
tissue culture treated plates using a 10% formalin solution for 1 hour. After fixation,
cells were washed with 60% isopropanol and incubated with an Oil-red-O dye solution
(0.7 grams Oil-red-O powder dissolved in 200 ml 100% isopropanol) for 10 minutes
before the detection of lipid accumulation. After incubation, cells were washed with
distilled water and allowed to dry at room temperature until all liquid was removed. An
aliquot of 100% isopropanol was administered to each cell treatment to elute all stained
lipids of dye. Lipid accumulation was measured from the eluted dye of stained lipids
based on their absorbance at 520 nm in a 96-well microplate using a SpectraMax M5
spectrophotometer (Molecular Devices). Following lipid analysis, cells were washed
with PBS until all dye was removed and stained with a crystal violet dye solution to
detect the number of intact cells per treatment based on their absorbance at 595 nm.
Stained lipid values per treatment were normalized to the absorbance values of cells per
treatment.
Statistical Analysis
The effect of treatments on biochemical markers was assessed by mixed model
analysis using PROC MIXED in SAS for windows 9.4 (SAS Institute, Inc., Cary, NC).
Treatment was included as a fixed effect in separate models for each biochemical marker.
Experimental trials were included as a random effect. If treatment was significant,
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Tukey’s adjustment for multiple comparisons was used to determine differences in least
square means. A p-value of ≤ 0.05 was considered statistically significant based on least
square means differences for each treatment group. Graphical data were expressed as the
mean ± the standard error of the mean (SEM) for each treatment group repeated in
triplicate for each of 3 individual experimental trials.
Results
OA, an endogenous free fatty acid, was administered to induce lipid metabolism
and secretion from McA liver cells to verify that the assay was performed correctly.
After a 24 hour exposure with or without OA, McA liver cell ApoB secretion was
significantly increased in OA exposed cells compared to non-exposed basal lipid
secretion. Immunoblotting of the cell media detected that OA is a significant inducer of
ApoB secretion from liver cells as expected (Fig. 4.).
DDE exposure significantly increased ApoB secretion with increasing
concentrations compared to the controls. After a 24 hour exposure of cells to different
concentrations of DDE with co-exposure to OA, cell media was collected and subjected
to immunoblotting for the detection of ApoB proteins secreted into the media. DDE
exposure at 10 and 100 µM exhibited a positive concentration-response effect on ApoB
secretion (Fig. 5.).
DDE exposure increased ApoB secretion as concluded from the previous
protocol. Therefore the effect of DDE on lipid synthesis of ApoB in McA cells was
investigated. The analysis of intracellular ApoB levels from cell lysates based on DDE
exposure was determined using the previous concentration-response protocol. This
protocol identified that DDE at 10 µM significantly increased ApoB secretion. For all
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future experiments, McA cells were exposed to this concentration of DDE for 24 hours
with or without co-exposure to OA. Immunoblotting of the cell lysates indicated no
significant increase in intracellular ApoB protein levels for DDE exposed cells in the
presence or absence of OA compared to controls (data not shown).
The idea of whether DDE exposure may play a role in lipid transport by affecting
the intracellular assembly and formation of complete lipid products by way of neutral
lipid preservation and transport in McA liver cells was investigated. A 24 hour exposure
of McA cells to DDE with or without co-exposure to OA was administered to test this
hypothesis. Immunoblotting of cell lysates indicated an increase in intracellular MTP
protein levels for DDE exposed cells with co-exposure to OA, but not for DDE exposed
cells without OA compared to controls (Fig. 6.).
The idea of whether DDE exposure may affect ApoB secretion by altering
intracellular lipid degradation was investigated. Cell lysates from DDE exposure with or
without co-exposure to OA were subjected to immunoblotting. DDE exposure
significantly decreased the intracellular protein levels of Sort-1 with or without coexposure to OA after 24 hours (Fig. 7.).
The effect of DDE exposure on TG synthesis and accumulation was investigated
to identify any significant changes in TG accumulation levels in McA liver cells. After a
24 hour exposure to DDE with or without co-exposure to OA, cell lysates were subjected
to a colorimetric assay for the detection of intracellular TG levels. DDE exposure in the
presence of OA appears to decrease TG accumulation in liver cells, while the opposite
effect was observed in OA exposed cells (Fig. 8.). Cell media from these same studies
were extracted for lipid molecules and subjected to a colorimetric assay for the detection
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of TG secretion levels. DDE exposure with or without co-exposure to OA did not have a
significant effect on TG secretion levels (data not shown).
The idea of whether DDE exposure may play a role in the regulation of neutral
lipid accumulation was investigated. McA cells were exposed to DDE with or without
co-exposure to OA for 24 hours. Lipid accumulation was allowed to take place in liver
cells during this 24 hour period. OA induced neutral lipid accumulation was decreased in
the presence of DDE compared to controls. Based on these data, DDE exposure appears
to affect the accumulation of lipids by decreasing neutral lipid accumulation in liver cells
(Fig. 9.).
Discussion
Dichlorodiphenyltrichloroethane (DDT) was developed as one of the first
synthetic OC insecticides (CDC, 2012). OC exposure was once a prevalent event and is
still a threat to human health and the environment based on evidence of some OC
contaminants, DDE, being detected in soil, air, and water samples (EPA, 2011).
Individuals chronically exposed to OC may be at a greater risk of developing T2D or
exhibiting biochemical markers of T2D (Lee et al., 2007). Some of these biochemical
markers are regulated by the functions of the liver: lipid metabolism and secretion. DDE
exposure may cause adverse effects to the functions of the liver such as dyslipidemia and
was investigated in vitro.
Serum free fatty acid levels are elevated in T2D. Free fatty acids undergo
decreased beta-oxidation and increased esterification to produce more TG during insulin
resistance and dyslipidemia (Julius, 2003). Insulin resistance increases free fatty acid
lipid levels in the body, and ApoB levels are significantly higher in individuals with
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dyslipidemia and T2D (Qiu et. al, 2006). An increase in ApoB levels will potentially
result in adverse health effects because of the increased presence of TG molecules
available for metabolism that will further increase free fatty acid levels in the body,
thereby promoting dyslipidemia (Ginsberg et al., 2005). Although humans produce two
different forms of ApoB (ApoB-48/ApoB-100), measuring total ApoB levels may serve
as a more reliable biochemical marker for the prediction of metabolic dysfunction-related
diseases such as T2D. However, the livers of mice and rats express ApoB mRNA editing
activity and synthesize both forms of ApoB (Veniant et al., 1998). Therefore, this study
investigated total ApoB levels and their association with dyslipidemia in vitro.
Dyslipidemia is a characteristic of the metabolic syndrome and T2D. Exhibiting
biochemical markers of dyslipidemia including abnormal lipid levels is used in the
diagnosis of T2D (Benoist and Grand-Perret, 1996). There is an epidemiological
association between lipid biochemical markers and the prevalence of T2D (Kannel,
1985). OC exposure may further contribute to this epidemiological association (Ukropec
et al., 2010). For example, DDE exposure was a predictor of higher lipid levels over a
time course of 20 years post exposure in non-diabetics (Lee et al., 2011). One of the
liver’s functions is the synthesis and secretion of lipids and the disruption of that process
could have detrimental effects. The liver is susceptible to OC exposure as in vitro
research has shown adverse effects on liver cell function after OC exposure (Moser and
Smart, 1989). Therefore, the effect of exposure to the OC contaminant DDE on McA
liver cell function with respect to lipid metabolism and secretion was investigated and
identified a potential in vitro association with biochemical markers of dyslipidemia.
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These experimental data support the hypothesis that DDE exposure alters lipid
secretion levels in vitro and may serve as an important risk factor for predicting
dyslipidemia and T2D in vivo (La Merrill et al., 2014). Free fatty acid induced lipid
secretion yielded significantly higher levels of secreted ApoB lipids for DDE exposed
cells versus controls. Our immunoblotting techniques yielded detectable protein levels of
a lower molecular weight amino-terminal fragment of ApoB between 40-70 kDa as
observed in other studies (Macri and Adeli, 1997). DDE exposure appears to affect the
secretion of ApoB from free fatty acid stimulated McA liver cells, therefore suggesting a
role for DDE exposure in contributing to dyslipidemia.
Intracellular ApoB protein levels in cell lysates were not significantly different for
DDE exposed cells or OA exposed cells compared to controls, therefore diminishing a
role of DDE exposure in the regulation of ApoB synthesis. MTP protein levels in cell
lysates were increased in free fatty acid stimulated cells exposed to DDE, suggesting a
role of DDE in regulating the transport and assembly of ApoB containing lipids as
observed in other studies (Bartels et al., 2002). DDE exposure appears to affect
mechanisms that regulate ApoB degradation and may explain the increased secretion of
ApoB containing lipids observed in liver cells exposed to DDE. Sort-1 protein levels
were decreased in DDE exposed and OA exposed cells compared to controls in this study
indicating ApoB is rescued from intracellular degradation as observed in other studies
(Strong and Rader, 2012). DDE exposure decreased free fatty acid induced TG
accumulation, although no effect was observed with respect to TG secretion. DDE
exposure could decrease the rate of TG accumulation by regulating lipid transport
mechanisms or through induction of beta oxidation mechanisms.
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Neutral lipid transport is a vital mechanism in the lipidation or degradation of
ApoB molecules and their secretion. Neutral lipids such as TG and cholesterol are
synthesized from free fatty acids. Lipid accumulation depends on the regulation of lipid
secretion. In the liver, lipid accumulation will decrease as lipid secretion increases, and
will increase because of a decrease in lipid secretion (Ginsberg et al., 2005). Free fatty
acid induced intracellular TG and neutral lipid accumulation levels were decreased with
DDE exposure compared to controls. However, TG secretion levels did not differ
between DDE exposed cells compared to controls possibly due to lipid reuptake by liver
cells or poor recovery of lipid extracted molecules. Furthermore, previous in vitro
studies have shown that free fatty acid stimulation of ApoB secretion does not necessarily
increase levels of TG secretion (Chamberlain et al., 2013).
DDE exposure appears to play a role in dyslipidemia by affecting mechanisms
associated with lipid metabolism and secretion. DDE exposure seems to have a
significant effect on free fatty acid induced lipid accumulation and secretion and may
regulate intracellular proteins involved in lipid synthesis, transport, and degradation in
liver cells. One could further hypothesize that DDE exposure seems to rescue ApoB
from intracellular degradation by some unknown mechanism that may affect free fatty
acid beta oxidation, esterification, and/or intracellular protease activity.
These data support the hypothesis that DDE exposure is associated with McA
liver cell dyslipidemia by its effect on lipid synthesis, transport, accumulation,
degradation, and/or secretion (Fig. 10.). DDE exposure may exacerbate the liver’s
secretion of lipids thereby contributing to biochemical markers of dyslipidemia observed
in T2D. This in vitro mechanistic association may explain the epidemiological
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association of DDE exposure with biochemical markers of dyslipidemia and T2D (Lee et
al., 2011). These in vitro findings support data by others that DDE exposure is associated
with biochemical markers of dyslipidemia and T2D in vivo (Ruzzin et al., 2010).

45

Figure 3

Mechanism of Liver Cell Lipid Secretion.

Lipid secretion is induced by the metabolism of free fatty acids (FFA) to triglycerides
(TG). TG are transported to apolipoprotein B (ApoB) molecules to form lipidated ApoB.
Lipidated ApoB is then attached to very low density lipoproteins (VLDL) and secreted
from liver cells.
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Figure 4

(Panel A) Treatment of McA cells stimulated with 100 µM oleic acid (OA)
conjugated to 0.3% BSA, 400 µM OA conjugated to 1.2% BSA, or 1.2%
BSA only (vehicle) (V) for 24 hours. (Panel B) Western blot density of
ApoB secretion.

Measurement of ApoB secretion for treatments (OA) and vehicle control (V) in 3
experimental trials. Means that do not share the same letter are significantly different (p
≤ 0.05), as determined by a mixed model analysis with Tukey’s adjustment for multiple
comparison of least square means. Error bars represent the mean ± the standard error of
the mean (SEM) for each treatment group. ApoB secretion levels were increased after
OA exposure.
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Figure 5

(Panel A) Treatment of McA cells exposed to 1, 10, or 100 μM DDE
simultaneously with 400 µM oleic acid (OA) or 400 µM OA only for 24
hours. (Panel B) Western blot density of ApoB secretion.

Measurement of ApoB secretion for treatments (OA+DDE) and control (OA) in 3
experimental trials. Means that do not share the same letter are significantly different (p
≤ 0.05), as determined by a mixed model analysis with Tukey’s adjustment for multiple
comparison of least square means. Error bars represent the mean ± the standard error of
the mean (SEM) for each treatment group. ApoB secretion levels were increased after
DDE exposure at 10 and 100 µM. 1 µM DDE exposure did not have a significant effect
on ApoB secretion compared to control.
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Figure 6

(Panel A) Treatment of McA cells exposed to 10 µM DDE only or
simultaneously with 400 µM oleic acid (OA), 400 µM OA only, or 1.2%
BSA (vehicle) (V) for 24 hours. (Panel B) Western blot density of MTP.

Measurement of MTP protein levels of cell lysates for treatments (DDE, OA, OA+DDE) and
control (V) in 3 experimental trials. Means that do not share the same letter are significantly
different (p ≤ 0.05), as determined by a mixed model analysis with Tukey’s adjustment for
multiple comparison of least square means. Error bars represent the mean ± the standard error of
the mean (SEM) for each treatment group. Intracellular MTP protein levels were increased after
DDE exposure with co-exposure to OA.
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Figure 7

(Panel A) Treatment of McA cells exposed to 10 µM DDE only or
simultaneously with 100 µM oleic acid (OA), 100 µM OA only, or 0.3%
BSA (vehicle) (V) for 24 hours. (Panel B) Western blot density of Sort-1.

Measurement of Sort-1 protein levels of cell lysates for treatments (DDE, OA, OA+DDE)
and control (V) in 3 experimental trials. Means that do not share the same letter are
significantly different (p ≤ 0.05), as determined by a mixed model analysis with Tukey’s
adjustment for multiple comparison of least square means. Error bars represent the mean
± the standard error of the mean (SEM) for each treatment group. Intracellular Sort-1
protein levels were decreased after DDE exposure with or without co-exposure to OA.
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Figure 8

Treatment of McA cells exposed to 10 μM DDE only or simultaneously with
100 µM oleic acid (OA), 10 μM DDE only, 100 µM OA only, or 0.3% BSA
(vehicle) (V) for 24 hours.

Measurement of triglyceride accumulation in cell lysates of treatments (DDE, OA,
OA+DDE) and control (V) in 3 experimental trials. Means that do not share the same
letter are significantly different (p ≤ 0.05), as determined by a mixed model analysis with
Tukey’s adjustment for multiple comparison of least square means. Error bars represent
the mean ± the standard error of the mean (SEM) for each treatment group. OA
stimulated intracellular TG accumulation was decreased after DDE exposure.
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Figure 9

Treatment of McA cells exposed to 10 μM DDE simultaneously with 100
µM oleic acid (OA), 10 μM DDE only, 100 µM OA only, or 0.3% BSA
(vehicle) (V) for 24 hours.

Measurement of total neutral lipid accumulation in intact cells of treatments (DDE, OA,
OA+DDE) and control (V) in 3 experimental trials. Means that do not share the same
letter are significantly different (p ≤ 0.05), as determined by a mixed model analysis with
Tukey’s adjustment for multiple comparison of least square means. Error bars represent
the mean ± the standard error of the mean (SEM) for each treatment group. Free fatty
acid induced neutral lipid accumulation was decreased after DDE exposure.
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Figure 10

Proposed Mechanism of Dichlorodiphenyldichloroethylene (DDE) Induced
Lipid Metabolism and Secretion.

DDE exposure may exert its effect on free fatty acid (FFA) lipid metabolism and lipid
secretion by altering the function of biochemical markers involved in lipid synthesis and
degradation. DDE exposure decreases the protein levels of Sortilin-1 (Sort-1), reducing
apolipoprotein B (ApoB) degradation, while simultaneously DDE exposure increases the
protein levels of microsomal triglyceride transfer protein (MTP) which increases lipid
transport of neutral lipids such as triglyceride (TG) molecules in liver cells. This event
may preserve the overall protein levels of ApoB available for lipidation to form
completed lipid molecules such as very low-density lipoproteins (VLDL). The more
lipid molecules that are available in liver cells, the more lipids will be secreted from liver
cells. DDE exposure is an environmental factor that may alter lipid function in liver cells
that could promote dyslipidemia.
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IN VITRO EFFECT OF DDE EXPOSURE ON THE REGULATION OF B-TC-6
PANCREATIC BETA CELL INSULIN SECRETION AND ITS
ASSOCIATION WITH BETA CELL DYSFUNCTION
AND TYPE 2 DIABETES MELLITUS
Introduction
Epidemiological evidence in humans suggests that exhibiting higher levels of
some organochlorine compounds (OC), including dichlorodiphenyltrichloroethane
(DDT), and its metabolite, dichlorodiphenyldichloroethylene (DDE), is associated with
type 2 diabetes mellitus (T2D) (Lee et al., 2006). Based on recent literature, individuals
chronically exposed to DDE may be at a greater risk of developing T2D or exhibiting
biochemical markers of T2D (Lee et al., 2011). Individuals with T2D exhibit a decline in
the ability of their pancreatic beta cells to secrete insulin, which leads to beta cell
dysfunction, depletion of beta cell mass, and apoptosis (Dixon et al., 2004). The
pancreas is an organ that plays a role in regulating glucose homeostasis by the function of
its beta cells to produce sufficient amounts of the hormone insulin (Lim et al., 2011).
During T2D development, beta cells of the pancreas undergo physiological changes that
lead to beta cell dysfunction (Makaji et al., 2011). The pancreas could be a potential
target of OC exposure. Pancreatic beta cells of rats exposed to the OC endosulfan
exhibited swelling of the mitochondria resulting in mitochondrial dysfunction and
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yielding an increased risk of hyperglycemia (Kalendar et al., 2004). The OC DDE may
affect mechanisms in pancreatic beta cells that regulate biochemical markers of beta cell
dysfunction and T2D. Long-term exposure to DDE may affect how beta cells in the
pancreas synthesize and secrete insulin. Therefore, by using Beta-Tumor Cell-6 (B-TC6) murine pancreatic beta cells, the effect of DDE exposure on beta cell function was
investigated. B-TC-6 cells are a reliable cell line for insulin secretion studies because
they secrete sufficient amounts of insulin in response to glucose stimulation. B-TC-6
cells are derived from transgenic mice pancreatic beta cells expressing the pseudogene
construct composed of the simian virus-40 t-antigen (SV40) early region controlled by
the rat insulin II gene promotor responsible for insulin synthesis and secretion. However,
B-TC-6 cells do not respond to different concentrations of glucose in the same manner as
primary beta cells (Hohmeier and Newgard, 2004). B-TC-6 cells are derive from a
cancerous cell line (mouse insulinoma) and are not the best model for studying insulin
secretion compared to using primary cells of human origin.
The purpose of this study was to investigate the in vitro effect of DDE exposure
on the regulation of pancreatic beta cell function with respect to biochemical markers
implicated in beta cell dysfunction: insulin, pancreatic and duodenal homeobox factor-1
(PDX-1), prohormone convertase (PC), and reactive oxygen species (ROS). Insulin is a
secreted peptide hormone central to regulating carbohydrate and fat metabolism. Insulin
is synthesized and secreted by pancreatic beta cells in response to elevated extracellular
blood glucose concentrations (Itoh et al., 2003) (Fig. 11.). When control of insulin
regulation is altered, T2D will result (CDC, 2011). PDX-1 is a transcription factor
present in beta cells that regulates insulin gene transcription (McKinnon and Docherty,
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2001). Research by others has shown that the reduced expression of PDX-1 is associated
with beta cell dysfunction, hyperglycemia, and T2D (Brissova et al., 2005). PC is a
proteolytic enzyme responsible for the enzymatic cleavage of insulin to its mature form
for secretion from beta cells (Fu et al., 2013). Disruption of this enzymatic pathway
contributes to altered insulin secretion and beta cell dysfunction (Rhodes and Alarcon,
1994). ROS are a biochemical marker of oxidative stress and play a role in beta cell
function (Evans et al., 2003). Pancreatic beta cells express low levels of antioxidants and
oxidative stress has been associated with T2D development (Kahn, 2003). These
findings will potentially support the epidemiological association of DDE exposure with
T2D prevalence by testing our hypothesis: DDE exposure will adversely affect beta cell
function resulting in the altered synthesis and secretion of insulin from pancreatic beta
cells in vitro.
Materials and Methods
The B-TC-6 murine cell line and 0.05% trypsin in 0.53mM
ethylenediaminetetraacetic acid (EDTA) solution were purchased from American Tissue
Culture Collection (Manassas, VA). Certified fetal bovine serum (FBS), Dulbecco’s
Modified Eagles Medium (DMEM) with or without glucose, and penicillin-streptomycin
were purchased from Invitrogen (Grand Island, NY). p,p’-DDE was purchased from
Chem Service (West Chester, PA). Phosphate buffered saline (PBS) was purchased from
Mediatech Inc. (Manassas, VA). Radio-immunoprecipitation assay (RIPA) lysis buffer
system, PDX-1 antibody, insulin antibody, goat anti-rabbit IgG-HRP, beta-actin antibody,
and Western Blotting Luminol Reagent were purchased from Santa Cruz (Dallas, TX).
Dimethyl sulfoxide (DMSO), 2X-sodium dodecyl sulfate (SDS) sample loading buffer,
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bovine serum albumin-fatty acid free (BSA), hydrogen peroxide (H2O2), D-glucose,
pGlu-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin trifluoroacetate salt (p-Glu), and
2′,7′-dichlorodihydrofluorescein diacetate (DCFDA) were purchased from Sigma Aldrich
(St. Louis, MO). Non-fat dry milk and Bradford protein assay kit were purchased from
Bio-Rad (Hercules, CA). Super Signal West Pico Chemiluminescence kit was purchased
from Thermo Fisher Scientific (Pittsburgh, PA). High-throughput Time Resolved
Fluorescence (HTRF) Insulin Assay was purchased from Cisbio (Bedford, MA).
Mercodia Insulin Enzyme-Linked Immunosorbent Assay (ELISA) was purchased from
Mercodia (Winston Salem, NC).
B-TC-6 cells were grown in supplemented DMEM containing 15% heat
inactivated FBS and a 1% penicillin/streptomycin solution in a humidified atmosphere of
5% carbon dioxide and 95% air at 37°C until 70% confluent. Confluent cells were
washed with PBS and detached from the culture flask with a 0.05% trypsin in 0.53mM
EDTA solution. Cells were pelleted by centrifugation and re-suspended in supplemented
DMEM to be seeded overnight in a 12-well cell culture plate to adhere. The next day
supplemented DMEM was removed and adherent cells were washed with PBS and
treated with serum-free/glucose-free DMEM to starve cells of serum and glucose during
an overnight incubation. Following overnight incubation, serum-free/glucose-free
DMEM was removed and cells were washed with PBS and subjected to the following
experimental protocols.
Experimental Design
Experiment 1. The effect of glucose exposure on pancreatic beta cell function
was investigated with respect to insulin secretion levels. D-glucose was used to induce
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insulin secretion in B-TC-6 cells. Following standard cell culture protocols, serum and
glucose starved cells were treated with 0, 5, 10, or 15 mM glucose in DMEM for 2 hours
for a total of 4 treatment groups repeated in triplicate in each of 3 individual experimental
trials. Cell media was assayed for the detection of secreted insulin protein levels using an
immunoassay specific for insulin (Cisbio).
Experiment 2. The effect of DDE exposure on the regulation of insulin secretion
was investigated. Serum and glucose starved cells were treated with 10 µM DDE
dissolved in 0.1% DMSO, 1 µM H2O2, or 0.1% DMSO for 24 hours with or without coexposure to 5 mM glucose in DMEM for a total of 3 treatment groups repeated in
triplicate in each of 3 individual experimental trials. H2O2 was used as a positive control
to decrease insulin secretion. Cell media was assayed for the detection of secreted insulin
protein levels using an immunoassay specific for insulin (Cisbio).
Experiment 3. The effect of glucose exposure on intracellular ROS levels in BTC-6 cells was investigated. Serum and glucose starved cells were exposed to 0, 5, or 10
mM glucose in DMEM for 3 hours for a total of 3 treatment groups repeated in triplicate
in each of 3 individual experimental trials. Cells were assayed for the detection of
intracellular ROS levels using spectrophotometry.
Experiment 4. The effect of DDE exposure on ROS levels in B-TC-6 cells was
investigated. Serum and glucose starved cells were exposed to 10 µM DDE, 1 µM H2O2,
or 0.1% DMSO only with or without co-exposure to 5 mM glucose in DMEM for 3 hours
for a total of 3 treatment groups repeated in triplicate in each of 3 individual experimental
trials. Cells were assayed for the detection of intracellular ROS levels using
spectrofluorometry.
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Experiment 5. The effect of DDE exposure on the regulation of insulin
transcription with respect to PDX-1 and insulin protein levels was investigated. Serum
and glucose starved cells were exposed to 1, 10, or 100 µM DDE or 0.1% DMSO in
DMEM for 24 hours for a total of 4 treatment groups repeated in triplicate, or exposed to
10 µM DDE, 1 µM H2O2, or 0.1% DMSO for 24 hours with an additional exposure to 5
mM glucose in DMEM for 2 hours for a total of 3 treatment groups repeated in triplicate
in each of 3 individual experimental trials. Cell lysates were assayed for intracellular
PDX-1 and insulin protein levels using SDS-PAGE with Western Blot Analysis.
Experiment 6. The effect of DDE exposure on the regulation of post-translational
modification of insulin with respect to PC enzymatic activity was investigated. Serum
and glucose starved cells were exposed to 1, 10, or 100 µM DDE or 0.1% DMSO in
DMEM for 24 hours for a total of 4 treatment groups repeated in triplicate, or exposed to
10 µM DDE, 1 µM H2O2, or 0.1% DMSO for 24 hours with an additional exposure to 5
mM glucose in DMEM for 2 hours for a total of 3 treatment groups repeated in triplicate
in each of 3 individual experimental trials. Cell lysates were assayed for the detection of
PC enzyme activity using spectrophotometry.
Assay Development
Assay 1. Bradford Protein Analysis. Following all experimental protocols, the
cell media was collected and stored at -80°C and adherent cells were washed with PBS
and lysed in RIPA buffer with or without protease/phosphatase inhibitors and stored at 80°C for future analysis. The protein concentrations of whole cell lysates were separated
from cell debris after centrifugation at 16.1 RCF for 4°C using an Allegra X-14R
Centrifuge (Beckman Coulter). The protein concentrations of cell media and lysates
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from each treatment group were quantified by the Bradford protein assay. All treatment
groups were normalized to the protein concentrations of their respective cell lysates for
Western Blot Analysis.
Assay 2. SDS-PAGE with Western Blot Analysis. Protein concentrations were
normalized for all treatment samples using 50 mM Tris-hydrochloride buffer (pH 7.4 at
4°C). Equal amounts of 2X-SDS sample loading buffer were added to each treatment
sample at a 1:1 dilution. Diluted protein samples were heated at 95°C and allowed to
cool. After cooling, samples were pipetted at equal volumes per well on a 10%
polyacrylamide gel and subjected to electrophoresis for the separation of protein bands by
molecular weight at 100 volts for 15 minutes and 120 volts for 1 hour using a MiniPROTEAN 3 system. Following electrophoresis, the gel containing the protein bands
was transferred to a 0.45 μm polyvinylidene fluoride (PVDF) membrane with
electrophoresis at 20 volts for 30 minutes using a Trans-Blot SD semi-dry electrophoretic
transfer cell system (Bio-Rad). After a successful transfer, PDX-1 and insulin protein
levels were detected on a 0.45 μm PVDF membrane using the following antibodies:
PDX-1-primary antibody, insulin-primary antibody, beta-actin-primary antibody, and
goat anti-rabbit IgG-HRP-secondary antibody. Membranes were incubated with a
blocking solution (5% milk) to prevent non-specific binding of antibodies. Following
successful blocking, membranes were incubated with primary antibodies diluted 1:500 at
4°C overnight. After overnight incubation, membranes were washed with a solution of
Tris-buffered saline containing 0.05% Tween-20 for 15 minutes. After washing,
membranes were incubated with secondary antibodies diluted 1:2000 for 1 hour at room
temperature to detect protein bands. After washing again for 15 minutes, membranes
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containing the appropriate antibody conjugated proteins were subjected to a chemical
reaction of a 1:1 combination of super signal peroxide and luminol enhancer solution for
1 minute. The horseradish peroxidase conjugated to the secondary antibody mediated the
oxidation of luminol in the presence of hydrogen peroxide resulting in light emission or
chemiluminescence. Following this reaction, protein bands were visualized using the
Chemi-Doc XRS System with Image Lab Software (Bio-Rad). Protein band density was
quantified using ImageJ Software supplied by the National Institutes of Health (NIH).
Assay 3. Insulin Secretion Analysis. Cell media was collected and assayed for
insulin secretion levels. Fifty µl of cell media per treatment was pipetted into a 96-well
microplate. Twenty five µl each of anti-insulin Ab-cryptate and anti-insulin-Ab-XL665
antibodies were added to each sample well for the detection of insulin protein levels.
These two antibodies recognize insulin molecules simultaneously. When they are in
close proximity with each other, fluorescence resonance energy transfer (FRET) occurs
between them. This FRET increases as insulin concentration increases. Samples were
incubated for 2 hours at room temperature to increase antibody detection of insulin.
After incubation, insulin secretion levels were detected by measuring the FRET values
from each sample well at 620/665 nm using a SpectraMax M5 spectrophotometer
(Molecular Devices). Insulin levels were quantified using an insulin standard curve from
diluted solutions of purified insulin protein.
Assay 4. Intracellular ROS Analysis. After glucose or DDE exposure, cells were
washed with PBS and treated with a fluorescently labeled dye solution (25 µM DCFDA).
Cells were incubated for 1 hour with DCFDA to identify markers of oxidative stress
(ROS). DCFDA, a cell permeable fluorescent probe, is oxidized by intracellular ROS
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into a fluorescent product (2′,7′-dichlorofluorescein). Intracellular ROS levels in cells
were representative of oxidative stress levels and were measured fluorescently at 485/535
nm from intact cells or cell lysates in a 96-well microplate using a SpectraMax M5
spectrophotometer (Molecular Devices).
Assay 5. PC Enzymatic Analysis. Cell lysates were diluted with a solution (100
mM sodium acetate buffer, pH 6.0, 10 mM CaCl2) and incubated for 15 minutes.
Following incubation, cell lysates were treated with 25 µM p-Glu and incubated for 1
hour at 37°C in a 96-well microplate. p-Glu is a fluorescently labeled substrate for the
enzyme PC. After incubation, samples were measured for the hydrolysis of p-Glu to its
metabolite (amino-4-methylcoumarin) by intracellular protein levels of PC. PC
hydrolysis activity was measured from the fluorescent emission of the metabolite at
380/460 nm in a 96-well microplate using a SpectraMax M5 spectrophotometer
(Molecular Devices).
Statistical Analysis
The effect of treatments on biochemical markers was assessed by mixed model
analysis using PROC MIXED in SAS for windows 9.4 (SAS Institute, Inc., Cary, NC).
Treatment was included as a fixed effect in separate models for each biochemical marker.
Experimental trials were included as a random effect. If treatment was significant,
Tukey’s adjustment for multiple comparisons was used to determine differences in least
square means. A p-value of ≤ 0.05 was considered statistically significant based on least
square means differences for each treatment group. Graphical data were expressed as the
mean ± the standard error of the mean (SEM) for each treatment group repeated in
triplicate for each of 3 individual experimental trials.
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Results
Glucose was administered to induce insulin secretion from B-TC-6 cells to verify
that the cells were responding as expected. Cells were exposed to different
concentrations of glucose to investigate a concentration-response effect on insulin
secretion. Insulin secretion levels measured from immunoassaying of cell media were
quantified for the detection of any significant difference between glucose-exposed and
non-exposed cells. Exposure to glucose significantly increased insulin secretion in a
concentration-dependent manner (Fig. 12.).
The effect of DDE exposure plus glucose exposure on beta cell insulin secretion
was investigated. After a 24 hour exposure to DDE with or without exposure to glucose
for 2 additional hours, cell media was collected and subjected to immunoassay for the
detection of insulin secretion levels. Exposure of B-TC-6 cells to DDE caused a
significant increase in basal and glucose stimulated insulin secretion levels (Fig. 13.)
(Fig. 14.).
The idea that glucose metabolism induces changes in oxidative stress levels was
investigated. Therefore, a concentration-response effect of glucose exposure on beta cell
insulin secretion was measured. Exposure of B-TC-6 cells to increasing concentrations
of glucose increased ROS levels in conjunction with increasing insulin secretion, as
expected (Fig. 15.).
The idea that DDE exposure may regulate biochemical markers of oxidative stress
in B-TC-6 cells was investigated. Cells were exposed to DDE with or without glucose
for 3 hours to test this hypothesis. DDE exposure with or without glucose exposure
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yielded a trend towards increased ROS levels compared to controls, although not
significant (data not shown).
The effect of DDE exposure on the regulation of insulin synthesis by the
transcription factor PDX-1 was investigated. Immunoblotting of cell lysates for the
intracellular detection of PDX-1 revealed that DDE exposure alone yielded a trend for
increased PDX-1 protein levels compared to controls, although not significant (data not
shown). However, the opposite effect was observed from DDE exposed cells after
glucose stimulated insulin secretion, although not significant (data not shown).
The effect of DDE exposure on the regulation of post-translational modification
of insulin was investigated. The enzyme activity of endogenous PC from cell lysates
exposed to DDE with or without glucose stimulated insulin secretion was measured. PC
enzyme activity levels were increased in DDE exposed cells (Fig. 16.), but decreased in
DDE and glucose exposed cells (Fig. 17.).
Discussion
Multiple cell signaling pathways can be activated to affect the production of
insulin in beta cells (Fu et al., 2013). The abnormal regulation of pathways involved in
the synthesis and secretion of insulin can be detrimental to overall beta cell function
(Rhodes and Alarcon, 1994). Many factors can contribute to the altered regulation of
insulin signaling in beta cells. One factor such as the effect of DDE exposure on insulin
signaling has not been explored. Investigating this factor is significant because OC
including DDE are lipophilic compounds that persist for years in the environment and
bioaccumulate in organisms (CDC, 2012; EPA, 1999). Therefore, we investigated the
potential in vitro effect of DDE exposure on beta cell function because of the
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epidemiological association of DDE with T2D (Lee et al., 2007). Environmental
exposure to DDE could play a role in affecting biochemical markers of beta cell function,
potentially resulting in beta cell dysfunction and T2D development (Fig. 18.).
Overall, this study may explain the in vitro mechanisms behind the recent
epidemiological data that DDE exposure is a risk factor for the potential development of
T2D (Son et al., 2010). The purpose of the present study was to investigate whether in
vitro exposure to the environmental contaminant DDE leads to changes in beta cell
biochemical markers that are consistent with the development of T2D. Therefore, these
data support our hypothesis that DDE exposure alters beta cell function by the changes
observed in biochemical markers that regulate insulin secretion.
Glucose exposure had a significant effect on insulin secretion in this study similar
to the observations of others (Skelin et al., 2010). DDE exposure significantly increased
insulin secretion from B-TC-6 cells with or without co-exposure to glucose suggesting a
role in regulating insulin synthesis. ROS levels were not significantly different in DDE
exposed cells in the presence or absence of glucose diminishing oxidative stress a
possible mechanistic pathway for the regulation of insulin secretion. H2O2 exposure did
not increase ROS levels and decrease insulin secretion from beta cells, which was not
expected (Pi et al., 2007). DDE exposure may increase basal insulin secretion by
inducing cell mechanisms that regulate post-translational modification and insulin
secretion. PDX-1 protein levels in cell lysates were not increased in DDE exposed cells
compared to non-exposed cells diminishing a role of DDE in regulating insulin
transcription. DDE exposure may play a role in regulating insulin translational
modification by its effect on PC enzyme activity that is responsible for the synthesis of
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insulin in vitro. During non-glucose stimulation, DDE exposure increased overall insulin
secretion and PC levels in B-TC-6 cells. However, glucose stimulation after DDE
exposure only increased insulin secretion while decreasing PC levels. This could suggest
that DDE exposure initially increases insulin secretion but long-term may actually
decrease insulin secretion by blunting glucose induced regulation of insulin synthesis and
secretion. DDE exposure may cause similar effects observed in beta cell burnout
(hyperinsulinemia, increased cellular stress, and late-stage decreased insulin secretion) of
beta cells identified in the progression of T2D (Dixon et al., 2004). DDE exposure could
have an effect on the regulation of beta cell function by its adverse effect on insulin
synthesis and secretion, which over time could contribute to the progression of beta cell
dysfunction and T2D (Weir, 2004). Based on this study, one could hypothesize that
individuals exposed to high levels of the OC contaminant DDE may be at a greater risk of
exhibiting biochemical markers of beta cell dysfunction associated with T2D. The goal
of this research was to understand the potential adverse effects associated with the
exposure of environmental contaminants on human health and the environment and
associate environmental exposure as a possible factor in the development of chronic
diseases such as T2D.
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Figure 11

Mechanism of Pancreatic Beta Cell Insulin Secretion.

Glucose enters the beta cell through glucose transporter-2 (GLUT2). Once inside the cell
glucose metabolism increases the levels of adenosine triphosphate (ATP). ATP binds to
and closes the ATP-dependent-potassium channel (ATPK). This causes the cell
membrane to depolarize and opens the voltage-gated calcium channel (VGC). The
increased influx of calcium ions causes insulin that is stored in intracellular vesicles to be
released out of the cell resulting in insulin secretion.
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Treatment of B-TC-6 cells exposed to 0, 5, 10, or 15 mM glucose for 2
hours.

Measurement of insulin secretion for treatments (5, 10, 15 mM) and control (0 mM) in 3
experimental trials. Means that do not share the same letter are significantly different (p
≤ 0.05), as determined by a mixed model analysis with Tukey’s adjustment for multiple
comparison of least square means. Error bars represent the mean ± the standard error of
the mean (SEM) for each treatment group. Insulin secretion was increased with
increasing glucose concentrations.
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Treatment of B-TC-6 cells exposed to 10 µM DDE, 1 µM H2O2, or 0.1%
DMSO (vehicle) (V) without glucose for 24 hours.

Measurement of insulin secretion for treatments (DDE, H2O2) and control (V) in 3
experimental trials. Means that do not share the same letter are significantly different (p
≤ 0.05), as determined by a mixed model analysis with Tukey’s adjustment for multiple
comparison of least square means. Error bars represent the mean ± the standard error of
the mean (SEM) for each treatment group. Basal insulin secretion increased after DDE
exposure compared to control.
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Treatment of B-TC-6 cells exposed to 10 µM DDE, 1 µM H2O2, or 0.1%
DMSO (vehicle) (V) for 24 hours and stimulated an additional 2 hours with
5 mM glucose.

Measurement of insulin secretion for treatments (DDE, H2O2) and control (V) in 3
experimental trials. Means that do not share the same letter are significantly different (p
≤ 0.05), as determined by a mixed model analysis with Tukey’s adjustment for multiple
comparison of least square means. Error bars represent the mean ± the standard error of
the mean (SEM) for each treatment group. Glucose stimulated insulin secretion
increased after DDE exposure compared to control.
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Treatment of B-TC-6 cells exposed to 0, 5, or 10 mM glucose for 3 hours.

Measurement of intracellular ROS levels for treatments (5, 10 mM) and control (0 mM)
in 3 experimental trials. Means that do not share the same letter are significantly
different (p ≤ 0.05), as determined by a mixed model analysis with Tukey’s adjustment
for multiple comparison of least square means. Error bars represent the mean ± the
standard error of the mean (SEM) for each treatment group. ROS levels were only
increased with 10 mM glucose exposure.
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Treatment of B-TC-6 cells exposed to 1, 10, or 100 µM DDE or 0.1%
DMSO (vehicle) (V) for 24 hours.

Measurement of PC enzyme activity of cell lysates for treatments (DDE) and control (V)
in 3 experimental trials. Means that do not share the same letter are significantly
different (p ≤ 0.05), as determined by a mixed model analysis with Tukey’s adjustment
for multiple comparison of least square means. Error bars represent the mean ± the
standard error of the mean (SEM) for each treatment group. Although no concentrationresponse effect was observed with increasing DDE concentrations, basal PC enzyme
activity was increased after 10 µM DDE exposure compared to control.
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Treatment of B-TC-6 cells exposed to 10 µM DDE, 1 µM H2O2, or 0.1%
DMSO (vehicle) (V) for 24 hours and stimulated with 5 mM glucose for 2
hours.

Measurement of PC enzyme activity levels of cell lysates for treatments (DDE, H2O2)
and control (V) in 3 experimental trials. Means that do not share the same letter are
significantly different (p ≤ 0.05), as determined by a mixed model analysis with Tukey’s
adjustment for multiple comparison of least square means. Error bars represent the mean
± the standard error of the mean (SEM) for each treatment group. Although DDE
exposure alone increased basal PC levels, PC levels were decreased after glucose
exposure compared to control.
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Figure 18

Proposed Mechanism of Dichlorodiphenyldichloroethylene (DDE) Induced
Beta Cell Dysfunction.

DDE exposure may induce reactive oxygen species (ROS) levels, increase the expression
of the insulin transcription factor pancreatic and duodenal homeobox factor-1 (PDX-1),
or increase the enzyme activity of prohormone convertase (PC). Alteration in any one of
these processes increases the synthesis and/or secretion of insulin from beta cells,
representative of beta cell dysfunction. However, glucose exposure after DDE exposure
may further induce ROS levels while having no significant effect on PDX-1 and PC
protein levels. This produces the opposite effect of DDE exposure alone resulting in a
decrease of insulin secretion, which is also representative of beta cell dysfunction.
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DDE EXPOSURE IN A POPULATION EXHIBITING HIGH TYPE 2 DIABETES
PREVALENCE: AN EPIDEMIOLOGICAL ASSOCIATION OF
GEOGRAPHICAL EXPOSURE WITH BIOCHEMICAL
MARKERS OF TYPE 2 DIABETES MELLITUS
Introduction
The prevalence of type 2 diabetes mellitus (T2D) is increasing by the millions
every year worldwide (Amos et al., 1997). Because genetics can only explain a small
percentage of disease development, more attention is being given to environmental
exposure and disease association (Hunter, 2005). The prevalence of T2D has been
increasing with not all clear causes identified, while the use of synthetic chemicals has
risen (Neel and Sargis, 2011). Exposure to environmental contaminants is a factor that
could play a role in the pathogenesis of T2D (Lee et al., 2006; Carpenter, 2008). Belzoni,
MS, is an agricultural community in the Mississippi Delta region that was once highly
exposed to the synthetic organochlorine compound (OC) dichlorodiphenyltrichloroethane
(DDT) and is still polluted with levels of the environmental contaminant
dichlorodiphenyldichloroethylene (DDE) based on soil sample studies from our lab (340
ng DDE/g soil). The Mississippi Delta region also has a high prevalence of T2D, so the
associations of chemical contamination with disease prevalence should be investigated.
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Due to the increased epidemiological evidence of OC contaminants being
associated with T2D, the goal of this study was to investigate this association in a
population exhibiting a high prevalence of T2D which also has a high risk of OC
exposure. The working hypothesis for this study was that individuals currently living in
high exposure regions for OC who exhibit T2D or biochemical markers of T2D could
have higher than average levels of the OC contaminant DDE in their blood. Although
DDE levels might be found in all individuals, having higher levels detected in blood
samples from diabetics versus non-diabetics would support research by others of an
association with T2D (Lee et al., 2011). Therefore, the purpose of this study was to
investigate DDE exposure as a possible environmental risk factor for the association of
biochemical markers implicated in T2D: Apolipoprotein B (ApoB), triglycerides (TG),
and paraoxonase-1 (PON). ApoB plays an important role in lipid transport and clearance.
ApoB levels are significantly higher in individuals exhibiting dyslipidemia and T2D (Qiu
et. al, 2006). TG are synthesized from free fatty acids in the liver. TG are a biochemical
marker implicated in T2D and levels are usually higher in individuals with diabetes
compared to non-diabetics (Albrink and Man, 1958). PON functions as a protective
antioxidant against the oxidation of lipids. Previous epidemiological data concludes that
PON levels are decreased in T2D (Manning et al., 2012).
Materials and Methods
Human blood samples were collected from the Gorton Rural Health Clinic
(Belzoni, MS). Apolipoprotein B (ApoB) Enzyme-Linked Immunosorbent Assay
(ELISA) kit was purchased from Mabtech Inc. (Cincinnati, OH). Paraoxon (ultra pure)
was a generous gift from Dr. Howard Chambers from Mississippi State University
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(Mississippi State, MS). Phenyl acetate, acetonitrile, ethyl acetate, hexane, deionized
water, ethylenediaminetetraacetic acid (EDTA), calcium chloride (CaCl2), and bovine
serum albumin-fatty acid free (BSA) were purchased from Sigma Aldrich (St. Louis,
MO). Disposable pipette extraction (DPX) columns were purchased from DPX Labs
(Columbia, SC). Carbon-13-p,p’-DDT and carbon-13-trans-nonachlor internal standard
solutions were purchased from Cambridge Isotopes (Tewksbury, MA). Phosphate
buffered saline (PBS) was purchased from Mediatech Inc. (Manassas, VA).
Human blood samples were obtained from a population in which our laboratory
has obtained access through the Gorton Rural Health Clinic (Belzoni, MS) following
Institutional Review Board (IRB) approval by Mississippi State University (MSU).
Individuals within this population were patients of the Gorton Rural Health Clinic and
represent a small subset of the Mississippi Delta region. This study population consisted
of 77 subjects between the ages of 25 and 65 who were all females of African American
descent and living in the Mississippi Delta region. The demographic and clinical data of
each individual were collected by the study doctors and nurses from the Gorton Clinic
(height, weight, blood pressure, waist size, history of high blood pressure and smoking,
family history of heart disease, occupation, job history, use of medication, exposure to
pesticides, diabetes presence, heart disease, and lipid levels). Serum, plasma, red blood
cell, and urine samples were obtained from all individuals. Individuals were
compensated with a $10 gift card to a local department store for their participation. All
samples were collected with informed consent and public health records were kept
confidential. Samples were de-identified prior to any scientific and/or statistical analysis
by MSU researchers.
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Experimental Design/Assay Development
Assay 1. OC Extraction Analysis. Human plasma samples were tested for levels
of DDE with a solid phase extraction method using DPX columns with quantitation via
gas chromatography with mass spectrometry (GC/MS) detection. After obtaining human
plasma samples, aliquots of 1 ml were used for OC extractions. Samples were thawed
and 100 µl of an analytical internal standard mix of carbon-13-p,p’-DDT and carbon-13trans-nonachlor solution were added to 1 ml of each sample. The samples were vortexed
for 1 minute and allowed to incubate for 5 minutes at room temperature. Two ml of
acetonitrile were added to each sample and vortexed for 1 minute and incubated at room
temperature for 5 minutes. The samples were centrifuged at 1,200 x g for 10 minutes and
the supernatant was collected into clean test tubes. Two ml of deionized water was added
to the supernatant and the extract was aspirated using a DPX column for 30 seconds. The
liquid layer was extracted out of the column using a syringe and discarded. Following
the extraction phase, 0.5 ml of wash solution (33% acetonitrile in water) was aspirated
into the column for 10 seconds and discarded. One ml of elution solvent (1:1 ratio of
ethyl acetate/hexane) was aspirated into the column for 10 seconds and the eluent was
collected in a clean conical tube for a total of 2 times. The eluents were combined and
dried under a stream of nitrogen gas. The total eluent was resuspended with 100 µl
elution solvent and dried under nitrogen gas again. After drying, the eluent was
resuspended in a final solution of 100 µl elution solvent and placed in a GC vial with a
glass insert. The DDE levels in the final elution solvent were detected via GC/MS
detection.
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Assay 2. GC/MS Analysis. The analysis of DDE levels from the extracted
samples were quantified by isotope dilution via GC/MS. A targeted analysis using
isotope labeled internal standards were administered using the single ion monitoring
(SIM) mode of the 6890N Network GC System (Agilent Technologies). This analysis
was used to quantify levels of the DDE analytes detected. The limit of detection (LOD)
is 100 pg/ml for DDE, and the mean percent recovery detected around 90%. DDE levels
from samples were detected using a 30m x 0.25mm i.d. DB-5MS column supplied by
J&W Scientific (Folsom, CA). Helium was administered as the carrier gas at a flow rate
of 1 ml per minute with an injector temperature of 275°C and a transfer line temperature
of 270°C. Each sample was analyzed with an average run time of 27.24 minutes. An
untargeted analysis was also performed using the full-scan mode of the GC/MS on a
random selection of samples in order to identify any additional OC pesticide analytes
detectable in the samples. All analytes detected were identified via Agilent
Technologies’ deconvolution reporting software and summated to the targeted analysis in
the SIM mode if detected in at least 50% of samples for analysis. OC levels expressed as
nanogram of OC analyte per milliliter of plasma (ng/ml) from each sample were adjusted
for the total plasma lipid levels for each subject, which is representative of total OC body
burden, since OC are lipophilic and are expected to partition in lipid molecules/adipose
tissue in the body (Schisterman et al., 2005). Thus, OC levels normalized on total blood
lipids (cholesterol esters, free cholesterol, phospholipids, and triglycerides) are a proxy
for adipose tissue OC levels. Lipid levels for each subject were calculated from their
clinical lipid data using the simplified equation, [total lipids (mg/dl) = 2.27 × total
cholesterol (mg/dl) + triglycerides (mg/dl) + 62.3)] which is derived from a broader
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equation described by Phillips et al. (1989), assuming a cholesterol ester percentage of
73% and the regression analysis between total cholesterol and phospholipid
concentrations. Total calculated lipid levels were expressed as gram of lipid per liter of
plasma (g/L), and lipid adjusted OC levels were standardized (plasma OC concentrations
divided by plasma lipids concentrations) and expressed as ng of OC analyte per gram of
lipid (ng/g) (Bergonzi et al., 2009).
Assay 3. ApoB Analysis. Human serum samples were analyzed for the detection
of ApoB levels using an immunoassay specific for human ApoB (Mabtech, Inc.). Clear
microplates (96-well) were coated with 100 µl per well of a monoclonal antibody (LDL
20/17) solution diluted to 2 µg/ml, and incubated overnight at 4°C. Following
incubation, plates were washed with PBS and blocked for non-specific binding using 200
µl of PBS with 0.05% Tween-20 containing 1% BSA at room temperature for 1 hour.
After blocking, plates were washed with PBS and 100 µl of serum samples and standards
were added in triplicate wells and incubated at room temperature for 1 hour. Plates were
washed with PBS and ApoB antigen levels were targeted using 100 µl per well of a
biotinylated monoclonal antibody (LDL 11) solution diluted to 1 µg/ml with incubation
for 1 hour at room temperature. Plates were washed with PBS and incubated with 100 µl
per well of a detection antibody solution, streptavidin-horseradish peroxidase diluted
1:1000, for 1 hour at room temperature. After incubation, plates were washed with PBS
and incubated in 100 µl of tetramethylbenzidine (TMB) substrate solution (T-0440) for
15 minutes in the dark. A stop solution of 50 µl 1N sulfuric acid (H2SO4) was added to
the TMB solution to produce a colored product representative of ApoB protein levels.
This colored product was measured at 450 nm using a ThermoMax spectrophotometer
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(Molecular Devices). ApoB levels were quantified using a calibrated human recombinant
ApoB standard that yielded a standard curve representative of ApoB levels.
Assay 4. PON Enzymatic Analysis with Paraoxon. Human serum samples were
investigated for the quantitation of PON enzyme activities based on the hydrolysis of
paraoxon (Fig. 19., A). Human serum samples were thawed at 37°C and stored on ice
until further analysis. One hundred seventy five µl of calcium buffer solution (0.2 M
Tris-hydrochloride (HCl), 2 mM CaCl2, pH 8.0,) per sample was added in triplicate
amounts to the first 3 wells on the first two rows of a 96-well clear microplate. One
hundred seventy five µl of EDTA buffer solution (0.1 M Tris-HCl, 1 mM EDTA, pH 8.0)
per sample was added in triplicate amounts to the first 3 wells on the third row of a 96well clear microplate for a total of 9 wells per sample. Sixty µl of calcium buffer
solution was added to 3 microcentrifuge tubes per sample along with 15 µl of serum in
the same tubes. Forty µl of EDTA buffer solution was added to 3 microcentrifuge tubes
per sample along with 10 µl of serum in the same tubes. All samples were vortexed and
remained on ice until further analysis. Twenty five µl of the calcium dilution was added
to the first 3 wells on the first two rows per sample and 25 µl of the EDTA dilution was
added to the first 3 wells on the third row per sample. The samples were incubated on a
plate shaker for 5 minutes at 37°C. After incubation, 2 µl of a solution of 1.2 mM
paraoxon dissolved in ethanol was added to all sample wells. Samples were further
incubated at 37°C on a plate shaker for an additional 20 minutes. Following final
incubation, 50 µl of enzyme stop solution (20 mM EDTA with 2% Tris-base dissolved in
H2O) was added to inhibit further enzyme activity. Enzyme esterase activity was
measured from the production of the paraoxon metabolite, p-nitrophenol and quantified at
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405 nm using a Sunrise spectrophotometer (Tecan). EDTA inhibited PON activity levels
were subtracted from calcium activated PON activity levels per sample to yield the total
mean levels of PON activity.
Assay 5. PON Enzymatic Analysis with Phenyl Acetate. Human serum samples
were investigated for the quantitation of PON enzyme activities based on the hydrolysis
of phenyl acetate (Fig. 19., B). Human serum samples were thawed at 37°C and stored
on ice until further analysis. Nine hundred ninety µl of calcium buffer solution was
added to duplicate microcentrifuge tubes and the same amount of EDTA buffer solution
was added to a third microcentrifuge tube for a total of 3 tubes per sample. All sample
tubes were incubated at 37°C in a water bath with gentle shaking for 3 minute intervals
per sample. Ten µl of serum was added to all three tubes per sample, vortexed, and
incubated at 37°C for 10 minutes. After incubation, 10 µl of 50 mM phenyl acetate
dissolved in ethanol was added to each triplicate sample tube and vortexed for 5 seconds.
The sample solution from each tube was aliquoted into ultraviolet cuvettes and PON
hydrolysis activity was measured at 270 nm using a BioMate 3 spectrophotometer
(Thermo Scientific). Arylesterase activity of phenyl acetate hydrolysis via PON to its
metabolite, phenol, was detected over a 2 minute interval. Enzyme activity was
quantified as the yield of calcium activated enzyme activity minus EDTA inhibited
enzyme activity.
Statistical Analysis
All data analyses were performed using Statistical Analysis Software (SAS) for
Windows version 9.4 (SAS Institute, Inc., Cary, NC). DDE, APOB, TG, PON and other
biochemical markers (parameter levels): high density lipoproteins (HDL), low density
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lipoproteins (LDL), cholesterol (CHOL), body mass index (BMI), fasting blood glucose
(FBG), hemoglobin A1C (HGAC), use of statins (STAT), use of fibrates (FIB), use of
niacin (NIA) use of tobacco (TOB), and age (AGE), were collected from each individual
to test for any significant association with T2D presence. Descriptive statistics of
parameter levels for continuous variables of diabetics and non-diabetics were analyzed
using PROC UNIVARIATE to identify means ± standard deviation (SD) values, while
PROC FREQ was used to compare categorical variables of diabetics and non-diabetics to
identify proportional values. Basic linear regression analysis was used to test for any
significant correlation between DDE levels and other parameter levels using PROC
GLM. Univariable logistic regression analysis was used to test for any significant
association of individual parameter levels with increased T2D risk by measuring odds
ratios (OR) and 90% confidence interval (CI) for each parameter using PROC
LOGISTIC. Individual parameters associated (p ≤ 0.25) with T2D risk were used as
candidates for development of a multivariable logistic regression model using PROC
LOGISTIC. Because of the small sample size, a p-value of ≤ 0.1 was considered
statistically significant and a CI including the numeral 1 as a value was considered not
statistically significant.
Results
Following the collection of all clinical and demographic data for each individual,
descriptive statistics of parameter levels for diabetics and non-diabetics were analyzed
(Table 1.). Based on our analysis, DDE, ApoB, PON, BMI, and AGE levels were similar
for diabetics and nondiabetics. FBG levels, which is used to diagnosis diabetes, were not
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similar for diabetics and non-diabetics as expected. However, HGAC levels, which is
also used to diagnosis diabetes, were similar for diabetics and non-diabetics.
All parameters were analyzed for their potential individual association with T2D
presence using logistic regression analysis. Based on the statistical analysis, HDL levels
(OR=0.955, p-value=0.0436), FBG levels (OR=1.037, p-value=0.0029), PHAC levels
(OR=1, p-value=0.1312), and STAT levels (OR=0.387, p-value=0.0620) were
significantly associated with T2D, p-value ≤ 0.25 (Table 2.).
Parameters significant for T2D risk from the univariable logistic regression
model: HDL, PHAC, and STAT levels (except for FBG which is representative of
diabetes diagnosis), were subjected to multivariable logistic regression analysis to test for
any significant combined association with T2D risk. After identifying the best model,
parameter levels for DDE were added to the final model to observe a potential association
for increased T2D risk. Based on our analysis, there was not a significant increase in
association for any parameter with T2D risk, even though HDL and STAT levels both
yielded a p-value ≤ 0.1 (Table 3.). DDE levels did not increase the risk of association for
these parameters with T2D.
Because no association was found for DDE and other parameters with T2D using
logistic regression analysis, DDE levels were investigated for any significant association
with other biochemical markers/parameters of T2D from this study using linear
regression analysis. Based on the results, only AGE and HGAC levels were found to be
associated with DDE levels, p-value ≤ 0.1 (Table 4.). DDE levels were not associated
with any significant trend among lipid levels for diabetics and non-diabetics.
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Discussion
Genetic factors contribute to only a small portion of the pathology of disease
development in organisms. A majority of non-genetic factors including environmental
factors may play a large role in the progression of metabolic diseases (Neel and Sargis,
2011). Past epidemiological data has linked many adverse health effects in humans to
exposure to environmental chemicals including DDE (Lee et al., 2006). Research by
others has shown an epidemiological association between individuals with or at risk for
T2D and the presence of higher levels of DDE in their blood (Lee et al., 2007). In a
study by Ukropec et al. (2010), OC exposure was associated with an increased risk of
diabetes prevalence in a population living in a highly polluted area in Eastern Slovakia
for persistent organic pollutants based on OC levels found in their serum:
(DDE:OR=1.86, CI=1.17-2.95) (DDT:OR=2.48, CI=1.77-3.48). Individuals in the upper
quintiles of this study exhibited average DDE levels ≥ 1,500 ng/g, similar to the DDE
levels observed from our study population. Data from the NHANES study showed that
serum levels of OC from a population exhibiting diabetes were associated with diabetes
prevalence: (DDE: OR=2.3, CI=1.0-5.5) (Lee et al., 2006). Also, DDE levels from the
NHANES study were detected in over 90% of samples, which was similar to DDE levels
detected in our study. OC levels from a population in South Korea with low level
background exposure were associated with diabetes risk: (DDT: OR=10.6, CI=1.3-84.9)
(DDE: OR=12.7, CI=1.9-83.7) (Son et al., 2010). Diabetic individuals from this study
exhibited serum DDE levels around 650 ng/g, which was similar to the lower quintiles
plasma DDE levels of diabetic and non-diabetics from our current study and a previous
study by Eden et al. (2014). DDE levels from this South Korean population exhibited an
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even higher risk of association with diabetes prevalence when they were adjusted to the
covariates BMI and AGE. Thus, higher BMI and AGE levels were both correlated with
DDE levels from this study, but only AGE levels (p-value ≤ 0.1) were correlated with
DDE levels from our study. However, Eden et al. (2014) showed that DDE levels were
associated with diabetes prevalence with increasing AGE levels and decreasing BMI
levels, although our study showed no statistically significant difference for average BMI
and AGE levels between diabetics and non-diabetics. Also, BMI levels were not a
significant risk factor for diabetes prevalence in African Americans from our study,
similar to studies by Eden et al. (2014). A study by Lee et al. (2011) showed that low
dose DDE levels predicted higher BMI and triglyceride levels in non-diabetics over a 20
year time period, while studies by Turyk et al. (2009) showed that high DDE levels were
associated with diabetes prevalence over a 20 year time period.
Long-term DDE exposure has been associated with an increase of lipid levels
based on epidemiological studies (Lee et al., 2011). Animal studies have also shown a
positive association between OC levels and biochemical markers of dyslipidemia (La
Merrill et al., 2014). ApoB is a biochemical marker of dyslipidemia implicated in T2D
and was also a parameter investigated in this study (Qiu et al., 2006). DDE exposure is
associated with abnormal lipid profiles and with T2D, while lower levels of PON activity
have been observed in T2D (Ruzzin et al., 2010). PON is attached to HDL lipids and
HDL lipids are decreased while LDL lipids are increased in T2D (Manning et al., 2012).
Therefore, PON levels could vary in the body based on certain pathophysiological
conditions such as T2D. Diabetics are known to have decreased PON levels compared to
non-diabetics (Ikeda et al., 1998). Variations in PON activity levels are due to changes in
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lipid levels, which could be affected by DDE exposure. PON levels are directly
associated with lipid levels of HDL (Aviram et al., 1999; Abbott et al., 1995). However,
lower HDL and higher LDL levels implicated in dyslipidemia contribute to lower PON
levels (Saha et al., 1991). Diabetics exhibit higher LDL and lower HDL levels as well as
lower PON levels (Shamir et al., 2005).
This Mississippi Delta population is significant because it has a high prevalence
of T2D. Our study hypothesis was that individuals living in a high risk exposure area for
OC could have higher than average exposure levels of DDE in their blood and exhibit
biochemical markers associated with T2D. This epidemiological study from our lab
identifying DDE levels in blood samples from diabetics and non-diabetics could
potentially support research by others of DDE levels being associated with T2D (Taylor
et al., 2013). Based on the results of this study, DDE levels were not a significant risk
factor for directly predicting T2D presence: (DDE: OR=1, CI=1.00-1.00) compared to
another study from our lab observing OC levels in a United States Air Force study (DDE:
OR=1.56, CI=1.22-1.99) (Eden et al., 2014). Therefore, it was important to identify if
DDE levels may be indirectly associated with biochemical markers of T2D. DDE levels
were only associated with HGAC and AGE levels. However, this study does not support
our overall hypothesis of DDE levels being associated with T2D presence.
The Mississippi Delta region is a high exposure area for DDE contamination.
This could explain why plasma DDE levels were not significantly different between
diabetics (2,169 ± 4,041 ng/g lipid) and non-diabetics (1,890 ± 2,236 ng/g lipid). Higher
DDE levels in individuals may reach a certain level of saturation until there is no real
relationship observed with T2D. Serum ApoB levels were not greater in diabetics (260 ±
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118) compared to non-diabetics (257 ± 113). Therefore, these data do not support
previous research by others finding an association of OC exposure with lipid biochemical
markers of T2D. Serum PON levels were not significantly different between diabetics
(147 ± 44) and non-diabetics (140 ± 56), which was not expected. DDE levels were not
directly associated with T2D presence based on our epidemiological studies probably due
to the small sample size and all samples being selected from a high exposure area for OC.
Therefore, obtaining results from a larger study sample is needed before any conclusions
can be derived. Studies by others observing a relationship between DDE and T2D in
individuals with high body burdens of DDE levels is interesting compared to our study
which found no association with high DDE levels and T2D. This study does not support
previous studies that identified DDE levels with T2D association. Regardless of
scientific outcome, understanding the epidemiological and physiological association of
OC compounds with chronic diseases such as T2D is vital in determining their overall
impact on human health and the environment.
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Figure 19

Metabolism of paraoxon (A) and phenyl acetate (B) by paraoxonase.
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Table 1

Descriptive Statistics of Parameter Means for Diabetics (D) and Nondiabetics (ND).

Measurement of parameter levels between groups for n=77 samples, mean ± the standard
error of the mean (SEM). Parameters measured were dichlorodiphenyldichloroethylene
(DDE), apolipoprotein B (APOB), paraoxon hydrolysis (PON), phenyl acetate hydrolysis
(PHAC), triglyceride (TG), body mass index (BMI), age (AGE), high density lipoprotein
(HDL), low density lipoprotein (LDL), cholesterol (CHOL), hemoglobin A1C (HGAC),
fasting blood glucose (FBG), statin (STAT), tobacco (TOB), fibrate (FIB), and niacin
(NIA). All Parameter levels excluding FBG levels were not significantly different
between groups based on mean values.
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Table 2

Univariable Logistic Regression Analysis.

Statistical association of each parameter with T2D prevalence. Parameters measured
were dichlorodiphenyldichloroethylene (DDE), apolipoprotein B (APOB), paraoxonase-1
(paraoxon (PON)/phenyl acetate (PHAC), low density lipoprotein (LDL), high density
lipoprotein (HDL), triglyceride (TG), body mass index (BMI), age (AGE), hemoglobin
A1C (HGAC), fasting blood glucose (FBG), cholesterol (CHOL), statin (STAT), and
tobacco (TOB). Measurement of an individual association with T2D prevalence based on
odds ratios (OR), 95% confidence interval (CI), and p-values for each parameter for n=77
samples. A p-value of ≤ 0.25 was considered statistically significant. HDL, PHAC,
FBG, and STAT levels were found to be associated with increased T2D risk.
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Table 3

Multivariable Logistic Regression Analysis.

Statistical association of all significant parameters for T2D risk. Parameters measured
were dichlorodiphenyldichloroethylene (DDE), high density lipoprotein (HDL), and
statin (STAT). Measurement of a combined risk for T2D presence using odds ratios
(OR), 95% confidence intervals (CI), and p-values for each parameter for n=77 samples.
A p-value of ≤ 0.1 was considered statistically significant. There was no significant
increase in risk for T2D among combined parameters.
Table 4

Linear Regression Analysis.

Statistical association of dichlorodiphenyldichloroethylene (DDE) levels with predicting other parameters
of T2D. Parameters measured were apolipoprotein B (APOB), paraoxon hydrolysis (PON), phenyl acetate
hydrolysis (PHAC), low density lipoprotein (LDL), high density lipoprotein (HDL), triglyceride (TG),
body mass index (BMI), age (AGE), hemoglobin A1C (HGAC), fasting blood glucose (FBG), and
cholesterol (CHOL). Measurement of an individual association of DDE with other parameters of T2D
based on R-square and p-values for n=77 samples. A p-value of ≤ 0.1 was considered statistically
significant. DDE levels were found to be associated with AGE and HGAC levels.
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CONCLUSIONS
The threat of dichlorodiphenyldichloroethylene (DDE) exposure is still relevant
based on evidence of all living organisms exhibiting some level of DDE contamination.
Some adverse effects of DDE exposure have been identified while other effects have yet
to be defined. One of those adverse effects is the association with biochemical markers
of metabolic diseases. Type 2 diabetes mellitus (T2D) is a metabolic disease associated
with many biochemical markers. These biochemical markers are significant in revealing
adverse effects to an organism. Individuals may be at a greater risk for exhibiting these
adverse effects in areas where contamination from dichlorodiphenyltrichloroethane
(DDT) exposure is ubiquitous in the environment. Thus, DDE exposure qualifies as an
environmental factor.
T2D prevalence has risen dramatically, especially in countries where DDT is still
be used and areas with historical exposure to high levels of DDE residues. Thus, DDE
exposure may be an environmental factor that is associated with the increasing
prevalence of T2D. DDE exposure may have a mechanistic association in T2D
development, although most scientific evidence claims only an observational association
of DDE exposure with T2D. Based on results from this study, DDE exposure appears to
be associated with dyslipidemia and beta cell dysfunction by its effect on liver hepatocyte
and pancreatic beta cell function in vitro, although no direct association of DDE exposure
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with T2D was found in epidemiological studies. The regulation of lipid metabolism and
secretion in McA liver cells was significantly altered as a result of DDE exposure. DDE
exposure altered the levels of proteins involved in regulating lipid metabolism and
secretion implicated in dyslipidemia. DDE exposure significantly altered insulin
synthesis and secretion levels in B-TC-6 cells. The levels of proteins involved in
regulating insulin synthesis and secretion implicated in beta cell dysfunction were also
altered. DDE exposure may change how liver hepatocytes and pancreatic beta cells
function in maintaining protective mechanisms in order to prevent T2D development.
Long-term DDE exposure could favor the progression of dyslipidemia, beta cell
dysfunction, and potential T2D development. Dyslipidemia and beta cell dysfunction are
both contributors to T2D progression and any biological, chemical, or physical agent that
promotes liver dyslipidemia and/or beta cell dysfunction is therefore also contributing to
T2D progression. DDE contamination could be that chemical agent. This research
supported the findings of others who identified either an epidemiological and/or in
vitro/in vivo association of DDT/DDE exposure with T2D or biochemical markers of
T2D. An epidemiological association between biochemical markers and the prevalence
of T2D already exists, but DDE exposure may further contribute to this epidemiological
association.
Based on epidemiological studies, no significant association between DDE levels
and T2D was observed from this study population. However, DDE exposure was
associated with some biochemical/clinical markers (AGE, HGAC) implicated in various
metabolic diseases such as T2D. DDE exposure may have an indirect association with
T2D by its association with biochemical markers, which was also observed in some
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previous studies by others. Because of the small sample size of this study population, the
statistical power of tested parameters was probably diminished. All samples were
collected from African Americans, who are known to exhibit a higher prevalence of T2D,
and could play a role in explaining the lack of association of biochemical markers with
T2D prevalence in this population. It was concluded from this study that diabetics and
non-diabetics living in high exposure areas for DDE contamination exhibited no
significant difference among biochemical markers for T2D. Because all samples were
from high exposure areas for DDE contamination, this could explain the similarities
among biochemical markers between diabetics and non-diabetics because DDE exposure
could potentially play a role in regulating these biochemical markers based on
experimental studies by others. To continue, non-diabetics usually do not exhibit similar
biochemical markers clinical data when compared to diabetics. Research by others
supports the idea that DDE exposure has an individual association with some of these
biochemical markers and this could explain why levels were similar between both
groups. Randomly selecting samples from diabetics and non-diabetics from all regions of
Mississippi to observe DDE exposure would have been more significant. This study does
not support research by others of DDE exposure being associated with T2D. Overall, the
increasing prevalence of T2D may one day be explained by the increase in exposure to
environmental chemicals such as DDE, although more research is needed on this subject
matter.
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